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ABSTRACT 
Background: Quality of life (QoL) of cancer patients has been well researched, but not 
necessarily from the perspective of the patient and not in third world countries. Total care 
of cancer patients should encompass all aspects of the person, such as physical-, 
psychological- and social aspects, existential wellbeing and spirituality, in order to ensure 
optimal QoL. The purpose of the study was to explore QoL from the perspective of the 
cancer patient who accesses public health care services in South Africa for treatment and to 
develop and validate an appropriate patient-directed assessment instrument. 
Method: The study was conducted in two phases. In Phase 1 assessment of QoL was done by 
means of in-depth qualitative interviews. Open coding and template analysis was conducted 
\during data analysis and the applicable domains of QoL were identified. In Phase 2 an 
appropriate QoL assessment instrument was developed for cancer patients in South Africa. 
The Rasch Measurement Model was utilized for the validation of the instrument. 
Results: The domains of QoL identified by the cancer patients were: physical, psychosocial, 
financial, spiritual, existential and emotional. When compared with the domains included in 
available QoL assessment instruments such as the World Health Organization Quality of Life 
Instrument (shortened version) (WHOQOL-BREF), the European Organization for Research 
and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the Functional 
Assessment of Cancer Therapy General (FACT-G), the domains identified by cancer patients 
in South Africa were not fully addressed by these instruments.  
 
Significance of results: Culture, psychosocial status, financial aspects and spirituality play a 
major role in QoL of South African patients, as indicated by this study as well as a previous 
study on QoL of palliative patients from a resource-poor community in South Africa. These 
aspects of QoL are not addressed by the most commonly used assessment instruments. The 
importance of the utilization of an instrument which addresses all the appropriate domains 
of QoL is highlighted by the study.    
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CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
1.1 BACKGROUND AND RATIONALE OF THE STUDY 
 
Quality of life (QoL) of cancer patients has been well researched, but not necessarily from the 
perspective of resource poor cancer patients living in developing countries. It could be argued, 
that international literature can inform health care professionals caring for cancer patients; 
however South Africa faces unique health care challenges in terms of resources, access to care 
and late presentation with cancer. This study focused on the QoL of cancer patients accessing 
the public health care system in South Africa and aimed to add to the body of knowledge of 
cancer care in its attempt to develop and validate a patient-directed QoL instrument, which 
would be a first for South Africa. 
 
Cancer is a major health problem worldwide and affects people of all ages and walks of life. 
During 2012, 32.6 million people were living with cancer and 8.2 million people died of cancer 
worldwide.  According to the 2012 Globocan statistics, 57% of people newly diagnosed with 
cancer and 65% of cancer deaths occur in less developed regions annually (WHO, 2012). Cancer 
is one of the major causes of death in developed and less developed countries, including South 
Africa (CANSA, 2014a). Sixty thousand people newly diagnosed with cancer were reported in 
South Africa in 2008 (NHLS, 2008). 
 
Cancer care involves various treatment modalities, depending on the stage of disease. 
Irrespective of whether the goal of treatment is cure, control of disease or palliation, patients 
need to be supported through the cancer experience to ensure the best QoL possible for the 
patient and family. QoL is a broad, complex and highly individual concept and involves the total 
assessment of all aspects of daily life (Bennett and Closs, 2008). People’s QoL is influenced by 
their perceptions of their position in life in terms of their culture, value systems, personal goals 
and expectations (Diehr et al., 2007). QoL can also be described as the difference between the 
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hopes and expectations of an individual and what the person is experiencing at present. 
Expectations regarding QoL differ according to age and stage in the life cycle (Mitchell, 2001).  
 
South Africa hosts two health care systems: a private and public system. The public health 
sector delivers services to approximately 80% of the population. Public health care supports a 
district health care approach and follows a hierarchical referral system. The entrance point to 
public health care is the nurse-led primary health care clinics. Patients who cannot be managed 
at primary health care level are referred to district hospitals, while those patients needing 
specialised care, such as cancer care, are referred to tertiary hospitals. The system is not always 
followed and private patients also access health care at public hospitals, especially emergency 
care, which places a high burden on the hospital (Mojaki et al., 2011). The public health system, 
rendering health care which is free of cost, is under-resourced and the situation is worsened by 
the burden of diseases such as HIV/AIDS and TB (SouthAfrica.info, 2015).  Sophisticated cancer 
treatment is available to patients in both the private and public health care systems in South 
Africa (Abratt and Vorobiof, 2003).   
 
1.2 RESEARCH PROBLEM AND QUESTION 
 
The research problem for the study focused on the QoL of cancer patients using public health 
services.  In a previous South African study, exploring QoL from the perspective of resource 
poor palliative patients, it was found that QoL focused primarily on the ability to buy food and 
other basic commodities (Jansen van Rensburg et al., 2012). QoL however consists of more than 
basic needs and includes physical-, emotional-, social-, cognitive- and subjective dimensions 
(Mitera et al., 2010). The complexity of QoL and the assessment thereof is highlighted by a 
study by Maree and Jansen van Rensburg (2015), which suggests that QoL needs to be explored 
from the patient’s perspective, as commonly used QoL instruments might, similar to palliative 
patients, not be suitable for South Africa’s cancer patients. It was not known what QoL means 
to South African cancer patients who access public health care services for treatment and 
which domains of QoL would be included in an appropriate assessment instrument. 
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The research question is thus: 
 
What does quality of life mean, from the perspective of cancer patients in South 
Africa who access public health care services for treatment and which domains 
of quality of life would be included in an appropriate quality of life assessment 
instrument? 
 
1.3 PURPOSE AND AIMS OF THE STUDY 
 
The purpose of the study was to develop an appropriate QoL assessment instrument for cancer 
patients in South Africa. The study aimed to explore QoL from the perspective of South African 
cancer patients who access public health services for treatment and to develop and validate a 
patient-directed assessment instrument for cancer patients in South Africa.  
 
To fulfil the aims of the study, the study was conducted in two phases. In Phase 1, QoL was 
explored from the perspective of the cancer patient, while Phase 2 focused on the 
development, validation and pilot testing of the newly developed QoL assessment instrument.  
 
1.4 RESEARCH METHODS 
 
The study used mixed methods and was conducted in two phases in an academic hospital in 
Gauteng. In mixed methods research, both qualitative and quantitative approaches are 
followed and the integration of the data may involve philosophical assumptions. The use of this 
type of research may lead to a better understanding of the research problem (Cresswell, 2014). 
In this study quantitative findings were explained by means of qualitative probing. According to 
Polit and Beck (2008), some research questions require a mixed methods approach, especially 
in the social-, behavioural- and health sciences. There are several advantages to a mixed 
methods study, such as that the qualitative and quantitative approaches complement each 
other, it enhances the evidence base through triangulation and avoids the limitations of a single 
approach. Validity of findings is enhanced by multiple types of data which complement each 
other. A mixed method was chosen for this study to validate an instrument developed from 
data collected by means of qualitative interviews. Phase 1 used a qualitative approach, whilst 
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Phase 2 was quantitative. The research methods for each phase of the study will be 
summarised separately.  
 
1.4.1 Phase 1: Exploring QoL from the perspective of the cancer patient who accesses public 
health services in South Africa 
 
A qualitative exploratory design was selected for this phase of the study. The target population 
consisted of patients receiving treatment for cancer at an academic hospital in Gauteng 
Province, where both chemotherapy and radiation are administered. The inclusion criteria 
were: 18 years and older, receiving chemotherapy or radiation or both and willing to participate 
in the study. Purposive and convenience sampling selected the sample to include participants 
representing both male and female genders, different cancers and different cultural groups. 
Data saturation determined the sample size and the sample realised at 20, but two more 
interviews were conducted with patients with different cancers to confirm saturation. The data 
were gathered by means of qualitative interviews and analysed using Patton’s (2002) method 
of open coding. Thereafter template analysis was done.  
 
1.4.2 Phase 2: Development, validation and piloting of a Quality of Life Assessment 
Instrument for Cancer Patients in South Africa 
 
QoL categories identified during the qualitative interviews were operationalised into questions 
and two questionnaires were developed for the assessment of QoL; one questionnaire 
contained 67 questions regarding what reduced QoL (Addendum G) and the other 
questionnaire comprised 50 questions about what improved QoL (Addendum H). Each 
questionnaire was completed by 50 respondents, but nine of the questionnaires were 
incomplete and had to be discarded. The setting and target population was the same as for 
Phase 1 of the study.  Convenience and purposive sampling selected a sample of 100 (n=100) to 
pilot test the questionnaires. The responses were captured on two Excel spread sheets and 
subjected to the Rasch Measurement Model for validation. During the validation process, 50 of 
the questions in the two questionnaires were removed and some of the questions were 
rephrased for clarity purposes. The remaining 67 questions were combined into a new 
questionnaire determining what makes life good and what makes life hard (Addendum I), which 
   
 
5 
 
was again pilot tested using convenience and purposive sampling to recruit 200 respondents 
(n=200). One hundred and ninety nine (199) questionnaires were completed, 100 by patients 
receiving cancer treatment and 99 by patients seen for follow up six or twelve months after 
treatment. Of the 199 questionnaires, 195 were completed in full and were used for the 
validation of the instrument. The data were again captured on an Excel spread sheet and 
subjected to the Rasch Measurement Model.  
 
1.5 OUTLINE OF THE STUDY 
 
Chapter 1: Orientation to the study 
Chapter 2: Literature review 
Chapter 3: Research methods of Phase 1 
Chapter 4: Findings and discussion of Phase 1 
Chapter 5: Research methods of Phase 2 
Chapter 6: Results and discussion of Phase 2 
Chapter 7: Justification, limitations and recommendations 
 
1.6 SUMMARY 
 
In Chapter 1, the reader was orientated to the study. A background was given for the study, the 
research problem and methods were discussed; and the outline for the study was presented.  
Chapter 2 will present the literature review. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
Chapter 1 explained the background to the study and an overview was given of the research 
methods. In Chapter 2 a review of the literature will be presented. Cancer as a worldwide 
problem will be discussed, followed by a discussion of QoL and the measurement of QoL. 
 
2.2 CANCER AS A WORLD WIDE HEALTH PROBLEM  
 
According to the 2012 Globocan statistics, there were an estimated 14.1 million people newly 
diagnosed with cancer, 8.2 million people who died of cancer and 32.6 million people living 
with cancer within five years of their diagnosis in 2012 (WHO, 2012). More than 50% of the 
people newly diagnosed with cancer (57%), as well as the cancer deaths (65%), occurred in the 
less developed regions of the world. In addition, 48% of the population living with cancer within 
five years of their diagnosis lived in the less developed regions. More men than women were 
affected, as the overall standardised incidence rate of cancer in men was almost 25% higher 
than in women.  
 
In sub-Saharan Africa, the incidence of cancer is expected to increase by more than 85% in 
2030. This high incidence of cancer in sub-Saharan Africa is attributed to a lack of awareness of 
the cancer burden and the potential for prevention of cancer (Morhason-Bello et al., 2013). 
Tobacco, diet and infection, which are linked to an unhealthy life style, are three of the major 
causes of cancer. Tobacco use, responsible for more than 80% of lung cancer in men and 45% in 
women worldwide, is considered to be the world’s most avoidable cause of cancer. Dietary 
factors such as a low intake of fresh fruits and vegetables, being overweight and living a 
sedentary life style increase the risk of developing various cancers such as breast- and 
colorectal cancers. In addition, chronic infections with certain viruses can cause cancer. For 
instance, the human papillomavirus (HPV), a sexually transmitted virus, can increase a woman’s 
risk for cervical cancer 100 times, whilst infection with HIV leads to cancers such as Kaposi 
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sarcoma and lymphoma (CANSA, 2014b). The South African Cancer Association (CANSA) 
supports these statements and indicates that the high incidence of cancer in developing 
countries is aggravated by the high incidence of HIV, which increases the incidence of HIV-
related cancers such as Kaposi sarcoma, cervical cancer and lymphoma. In South Africa, an 
estimated one in six men and one in seven women would develop cancer in their life time 
(health24, 2014). According to CANSA (2014a), cancer is increasing in South Africa and is 
currently the sixth most common cause of death. 
 
Lung-, breast-, bowel- and prostate cancer are the most common cancers worldwide, of which 
lung cancer is the most common in male patients and causes the most cancer deaths 
worldwide. The majority of cancer deaths are caused by lung-, liver-, stomach- and bowel 
cancer (Cancer research UK, 2012). The top five cancers in men living in Africa are Kaposi’s 
sarcoma, liver-, prostate- and oesophagus cancer and non-Hodgkin’s lymphoma. In women 
living in Africa, the most common cancer is cervical cancer, followed by breast cancer, Kaposi’s 
sarcoma, liver- and stomach cancer (Sitas et al., 2006). In South Africa, the five most prevalent 
cancers in men are prostate cancer, cancer of an unknown primary, lung-, colorectal- and 
oesophageal cancer, and in women breast- and cervical cancer, cancer of an unknown primary, 
colorectal cancer and Kaposi’s sarcoma (CANSA, 2014a). 
 
According to the International Network for Cancer Treatment and Research (INCTR) (2015), 
more patients in developing countries die from cancer than in developed countries, due to late 
presentation at diagnosis and treatment. Various studies have been conducted in sub-Saharan 
Africa and have found that up to 90% of women present with advanced breast cancer (Stage III 
and IV), large tumours with a median size of 10cm and obvious lymph node disease (Porter, 
2009). The WHO (Mojaki et al., 2011) states most women in developing countries present with 
cervical cancer at an advanced stage and too late for effective treatment.  A study by Forbes et 
al. (2014) showed that there is a high incidence of males with prostate cancer who present with 
symptoms at a late stage. It is also the experience of the researcher that black African males are 
very reluctant to seek help from health service providers, even when symptomatic. 
 
Late presentation and diagnosis of cancer is also reported in the United Kingdom, which 
impacts negatively on survival rate and quality of life (Forbes et al., 2014). The following 
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reasons are given for delayed diagnosis of cancer: people who do not go for screening, 
insufficient cancer screening, inability to diagnose cancer or initiate treatment, ignoring of 
incidental findings, patients who do not recognise symptoms of cancer or do not seek 
healthcare when recognising symptoms. Studies in the UK confirmed that delayed diagnosis 
and treatment of cancer can be ascribed by patient delay, doctor delay – delay by the primary 
care practitioner and system delay – hospital- or secondary care delay. Reasons for patient 
delay have been described as interpretation of symptoms as common illnesses such as 
indigestion or colds, fear and anxiety related to the cancer diagnosis and fear of medical 
judgment. Socio-demographic factors which have an impact on late presentation are age – the 
higher the age, the less the knowledge of breast cancer risks and  symptoms-, and cultural 
issues such as difficulty examining Muslim patients for breast cancer due to Islamic laws 
prohibiting exposure of a woman to a man other than her husband. Factors which contribute to 
delays by healthcare practitioners are misdiagnosis, a lack of examination, co-morbidity and 
patient characteristics, such as socio-economic status and gender – men delay seeking help 
more than women. Delays caused by the health system are long waiting times for tests, 
referrals and follow up visits. In children delays in diagnosis and treatment of cancer are 
attributed to misinterpretation of symptoms by parents and healthcare providers (National 
Patient Safety Agency, 2010).  
 
People presenting with advanced cancer in the developing world face additional challenges to 
those of the developed world. Developing countries face further challenges such as a high 
burden of infectious disease such as HIV/AIDS and non-communicable diseases, poverty, 
insufficient government funding for health care and a shortage of health care professionals, 
especially trained in cancer care, resulting in a lack of sufficient resources for the diagnosis and 
treatment of cancer. Health care priorities in developing countries give preference to 
communicable diseases and treatment of non-communicable diseases is often not well 
structured (Maher et al., 2012). A shortage of surgeons skilled in cancer surgery, radiation 
oncologists and medical physicists, as well as radiation equipment and cytotoxic drugs, 
compounds the lack of effective cancer treatment offered to the patients in developing 
countries. Palliative care available to cancer patients is insufficient in many developing 
countries and health care providers are not trained in effective pain control (INCTR, 2015, 
CANSA, 2014b).   
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The incidence and severity of many cancers can be prevented or reduced by means of effective 
cancer screening programmes. For instance, in the United Kingdom screening is done for 
cervical-, breast- and colorectal cancer. Cervical screening is done by means of a Pap smear 
every three years for women between ages 26 and 49 and every five years in women 50 to 64 
years old. In case of a result which shows a low-grade lesion, an HPV test is done and if the virus 
is present, a colposcopy is done. Women between ages 50 and 70 are screened for breast 
cancer by means of mammogram. Men and women between ages 60 and 74 are screened for 
bowel cancer by means of a home testing kit for faecal occult blood and if the test is positive a 
colonoscopy is done (NHS, 2015).  
 
The American Cancer Society (2015) recommends screening for breast-, colorectal-, cervical-, 
lung- and prostate cancer. Women are advised to do mammograms annually from age 40 and 
to have a clinical breast examination every three years in their 20s and 30s and annually from 
age 40, whilst men aged 50 and older are advised to discuss testing for prostate cancer with 
their doctors and if they decide to be tested, have a PSA test. 
 
In the United States of America, screening for colorectal cancer is done by means of 
sigmoidoscopy every five years, colonoscopy every 10 years, barium enema every five years or 
CT colonography every five years to detect cancer or polyps, or annual faecal occult blood test, 
faecal immunochemical test or stool DNA test every three years to detect cancer. The American 
Cancer Society recommends screening for cervical cancer from age 21, by means of Pap smear 
every three years from age 21-29 and a Pap smear and HPV test every five years at age 30 to 65 
years. After age 65, testing is only done in case of previous positive results.  
 
In the USA, screening for lung cancer by means of a CT scan of the chest is advocated in persons 
55 to 74 years of age and who have been smoking a pack of cigarettes per day for 30 years or 
two packs per day for 15 years (American Cancer Society, 2015).  
 
Unfortunately a lack of financial and infrastructure resources in developing countries often 
makes screening for even cervical cancer,  by means of Pap smear, testing for HPV and 
colposcopy, impossible. The result is that more than 85% of cervical cancer deaths worldwide 
   
 
10 
 
occur in developing countries (Denny, 2015). Not having screening services is especially 
negative considering the fact that the incidence of cancer in sub-Saharan Africa is increasing 
rapidly and an 85% increase is expected by 2030. The problem is aggravated by a lack of 
awareness of the magnitude of the cancer burden and a lack of comprehension of the potential 
benefit of prevention of cancer. Morhason-Bello et al. (2013) recognise that collaboration is 
needed between countries, economies and professions to curb the rapidly increasing cancer 
burden.   
 
The South African National Department of Health’s strategic plan for the prevention of cancer 
focuses primarily on the prevention of cervical cancer. At present population-wide screening is 
not undertaken in South Africa. Apart from a policy on the prevention of cervical cancer which 
allows asymptomatic women three free of cost Pap smears at an interval of 10 years starting at 
the age of 30 (South African HPV Advisory Board, 2010), the Department supports community-
based screening and referral systems for adequate and relevant patient care. In addition, the 
strategic plan includes vaccination of 9 and 10 year old girls against the HPV virus, which was 
introduced in 80% of the poorest schools in the country from February 2014. Other cancer 
prevention strategies include regulations for limiting of trans-fats and salt in foods, reduction of 
tobacco use by means of limiting advertising of smoking and restrictions on smoking areas, and 
elimination of infant feeding bottles containing bisphenol A (CANSA, 2014a).  
 
Cervical cancer patients are often diagnosed and referred for treatment at such a late stage 
that only palliative care can be given, even though radiation, chemotherapy and surgery are 
available. Many of these patients are single parents and breadwinners, and in the prime of their 
lives. Even though cervical cancer is curable in the early stages, most of the patients in 
developing countries present too late for cure and with a very poor QoL (Maree et al., 2014).  
 
Cancer can be treated with surgery, radiotherapy, chemotherapy, biotherapy or hormonal 
therapy or a combination of different treatments, depending on the stage of the disease. The 
stage of the disease also dictates the goal of treatment which is cure, control or palliation. 
Surgery is used for diagnosis, staging of tumours, cure and palliation and can be used in 
combination with chemotherapy, radiation and immunotherapy as part of a multidisciplinary 
treatment and for prophylaxis in case of genetic predisposition to certain cancers (Gillespie, 
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2011). Radiotherapy is used as primary treatment or in combination with chemotherapy, 
surgery and biotherapy and for cure, control of disease and palliation (Gosselin, 2011), whilst 
chemotherapy is used as sole treatment in cancers such as haematological cancer, as 
neoadjuvant treatment before surgery in advanced disease, or in combination with radiation 
therapy as a radiation sensitizer (Tortorice, 2011).  
 
Each of the modalities of treatment has its own effects and side-effects, which may have a 
serious influence on the QoL of the patient and family. It is not only the treatment but also the 
cancer which has an effect on all aspects of a patient’s and family’s lives. It not only causes 
physical symptoms such as pain, fatigue and nausea and vomiting, but has an influence on 
mental and physical functioning, body image, psychological wellbeing, social- and financial 
aspects, roles and spiritual life (Ferrans, 2011).  
 
Ineffective communication about the diagnosis and goal of treatment can lead to confusion, 
anxiety and a lack of trust in the health care team. In addition, experiencing symptoms of 
cancer and not knowing what is wrong can be very distressing. Unfortunately patients are not 
always told the truth about the diagnosis due to medical traditions, religious values and cultural 
issues. Less than 50% of cancer patients globally are informed of their cancer diagnosis 
(Constantini et al., 2009).  
 
Communication problems can occur due to language barriers, educational level and cultural 
differences between the health care provider and the patient and family (Kristjanson, 2001). 
Patient preferences differ with regards to the communication of information about their 
prognosis, especially in advanced disease and in the palliative stage. The way in which 
information is communicated has an influence on the patient’s satisfaction, which is influenced 
by culture and educational level (Hagerty et al., 2005, Maree et al., 2014). In addition, factors 
such as being symptomatic, expecting the news or detecting the cancer during routine 
screening, previous experience and knowledge of cancer and whether the experience was 
positive or negative, influence the impact of a cancer diagnosis (Howard and Chady, 2012). 
Effective communication of the cancer diagnosis and the treatment plan is important for quality 
of life of the patient and family. 
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2.3 QUALITY OF LIFE 
 
2.3.1 Defining Quality of Life  
 
QoL is a complex phenomenon defined in various ways. There is no consensus on the definition 
of QoL. Bennett and Closs (2008) describe QoL as a broad, complex and highly individual 
concept and the total assessment of all aspects of daily life, whilst the WHO (1997) defines QoL 
as “individuals’ perception of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations, standards and concerns. 
It is a broad ranging concept affected in a complex way by the person’s physical health, 
psychological state, level of independence, social relationships, personal beliefs and their 
relationship to salient features of their environment” *p1+. The QoL of a person depends on the 
domains of QoL that the person considers as important (Theofilou, 2012). Ferrans and Hacker 
(2011) also acknowledge the multi-dimensionality of QoL and add that QoL is unique to the 
science and practice of nursing, as oncology nurses view patients from a holistic perspective 
throughout the trajectory of the cancer journey, including palliative care, end-of-life care and 
survivorship. QoL includes all aspects of life which are influenced by cancer and treatment, 
including physical symptoms and functioning-, mental-, social-, psychological- and spiritual 
aspects.    
 
As defined by the WHO (1997), QoL is based on the individual’s perception of his position in life.  
QoL does not only consist of objective indicators, such as income, living conditions and physical 
functioning, but also of subjective aspects such as the individual’s perception of important life 
domains and his/her satisfaction with those domains (Uwimana, 2005).   
 
Health-related quality of life (HRQOL) gives an indication of the health status of populations as 
well as the effectiveness of health systems (Romero et al., 2013). Cella et al., as quoted by Ding, 
Hu and Hallberg (2012), confirm that health-related QoL is both multi-dimensional and 
subjective and includes physical-, functional-, emotional- and social well-being. Dunn et al. 
(2013) confirm the multi-dimensionality of health-related QoL and include the social-, 
psychological- and physical domain. Personal beliefs and traditions have an important influence 
on perceptions of QoL.  Ferrans and Hacker (2011) agree that aspects of QoL are unique to 
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certain cultures, whilst Zeng et al. (2010) confirm the importance of culture by explaining the 
difference between the Western and Chinese concepts of QoL. In the Western culture, being 
healthy and independent, psychological wellbeing and having social relationships mean good 
QoL, whilst the Chinese cancer survivors value normal life, a good work, happiness, material 
resources and family support as important for QoL.  
 
South Africa is a religious country with all the cultural groups participating in religious activities 
(Countries and their culture forum, 2015). Being religious also has an effect on the experience 
of cancer and QoL, as supported by the findings of a study on quality of life of South African 
palliative patients living in a resource-poor community (Jansen van Rensburg, 2011). 
 
Apart from culture, various other factors influence QoL. According to Diehr and colleagues 
(2007), value systems, personal goals and expectations have an influence on a person’s QoL, 
which reflects a person’s evaluation of extrinsic and intrinsic circumstances. How persons rate 
their QoL depends on their subjective values of positive and negative aspects of life and does 
not depend on the presence or absence of problems. Patients in the same situation and stage 
of the illness trajectory may rate their QoL differently, as QoL is not equivalent to health status, 
but rather subjective wellbeing (Cohen, 2006).  Poverty plays a very important role in the QoL 
of cancer patients in sub-Saharan Africa and can be so overwhelming that QoL is determined by 
having food to eat and basic commodities, despite experiencing serious health problems 
(Jansen van Rensburg et al., 2012, Maree and Jansen van Rensburg, 2015).  
 
2.3.2 Domains of QoL 
 
As already mentioned, QoL consists of various domains or dimensions and authors differ in 
terms of these domains. Ferrans (2011), for instance, indicates QoL has four dimensions, health 
and physical functioning, social and economic, psychological/spiritual and family. Ferrans and 
Grant (Ferrans, 2011) agree with the four domains, but define them as the physical wellbeing 
and symptoms domain and the psychological-, social- and spiritual domains. Fitzsimmons and 
Middleton (2006) add to the domains by describing physical functioning, 
psychological/emotional-, cognitive-, social- and occupational domains, satisfaction with care 
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and global assessments, whilst Mitera et al. (2010) include physical-, emotional-, social-, 
cognitive- and subjective dimensions in QoL.  
For the purpose of the study, the researcher summarised the various domains as: physical-, 
social-, emotional/psychological-, financial- and spiritual, with each being discussed separately.  
 
2.3.2.1 Physical domain 
 
Ferrans (2011) describes the physical domain as the health and functioning domain, which 
includes the following: the person’s own health, whether the person experiences pain, has 
energy or a lack of energy and is fatigued, the ability to independently care for oneself, the 
ability to take care of family responsibilities, being useful to others, having worries and control 
over life, having the potential of living as long as you would like, having chances for a happy 
future, having a satisfactory sex life, having leisure time activities and having access to health 
care. Fitzsimmons and Middleton (2006) include mobility, self-care activities, activities of daily 
living such as household tasks, physical activity, symptoms of disease, and side-effects of 
treatment in the physical domain. Ferrell and Grant (Ferrans, 2011) include symptoms such as 
pain, fatigue, nausea, appetite and constipation, as well as sleep and rest and functional ability, 
and call the domain physical well-being and symptom domain. 
 
2.3.2.2 Social domain 
 
The social domain encompasses support, roles, friendship, family and feelings of belonging, as 
well as objective factors such as housing and education (Mandzuk and McMillan, 2005). Ferrans 
(2011) combines the social and economic domains and includes emotional support from 
friends, housing, neighbourhood, employment/unemployment, the ability to take care of 
financial needs and education in this domain. Ferrans (2011) also separates the social- and 
family domain and stresses the importance of relationships with the spouse, lover or partner, 
children and other family members, the health of the family and emotional support received 
from family members. Fitzsimmons and Middleton (2006) however separate the social domain 
from the occupational domain, which includes work activities and financial status. The social 
domain described by Ferrans (2011) includes the caregiver burden, roles, appearance, financial 
   
 
15 
 
burden and sexual functioning. Fitzsimmons and Middleton (2006) also include sexuality in the 
social domain and add the ability to carry out hobbies and interests and social isolation. 
 
2.3.2.3 Emotional/psychological domain 
 
Emotional wellbeing, spirituality, fulfilment, personal satisfaction and cognitive state are 
included in the psychological domain (Becker, 2007). Self-esteem and body image seem to be 
placed in various domains, as Fitzsimmons and Middleton (2006) place it in the 
psychological/emotional domain, whilst Ferrans (2011) considers it to be part of the social 
domain. In addition, Ferrell and Grant (Ferrans, 2011) and Fitzsimmons and Middleton (2006) 
combine the psychological- and emotional- in the psychological domain, including feelings of 
anxiety, depression, enjoyment, fear, happiness, satisfaction and coping. Ferrell and Grant 
(Ferrans, 2011) also separate the psychological and spiritual- domains, but in the conceptual 
model of Ferrans (2011), faith in God is included in the psychological/spiritual domain. Self-
esteem and satisfaction with life is sometimes also included in the spiritual domain (Tsewat, 
2006).  
 
2.3.2.4 Financial domain 
 
The financial aspect plays an important role in QoL, as illustrated by a previous study on QoL of 
palliative patients in a resource-poor community in South Africa (Jansen van Rensburg et al., 
2012). Financial aspects such as the cost of travelling, loss of income, medical costs and the cost 
of a caregiver play a major role in QoL, especially in patients from resource-poor communities 
(Fitzsimmons and Middleton, 2006). Factors such as being employed are also seen to be part of 
the social/economic domain and Ferrell and Grant include financial burden in the social domain 
(Ferrans, 2011).  
 
2.3.2.5 Spiritual domain 
 
The spiritual domain is very important to some patients but not important to others and may 
have a positive or negative influence on QoL (Mandzuk and McMillan, 2005).  The term 
“spirituality” may mean different things to different people and the term is often misused in 
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literature (Wein, 2014). From the literature, it appears that the terms spirituality and religion 
are used interchangeably and are linked. Spirituality can be described as a person’s values and 
beliefs, what gives meaning and purpose to the person’s life, a sense of identity or religion 
(Egan et al., 2011), but Wein (2014) is of the opinion that the definition is vague and that the 
concepts overlap.  He distinguishes between spirituality and emotion and describes spirituality 
as an awareness of becoming one with something other than the self and involves a changed 
state of consciousness, which is different from an emotion. Tsewat (2006) associates 
psychological characteristics such as optimism, self-esteem and satisfaction with life with 
spirituality, and religion with religious practice. According to Ferrell and Grant (Ferrans, 2011), 
religiosity is included in the spiritual domain, as well as hopefulness, suffering, meaning of 
illness, transcendence and uncertainty, but in the conceptual model of Ferrans, faith in God is 
included in the psychological/spiritual domain. Maree et al. (2015) describe religion and hope 
as existential issues. Other existential issues which have an impact on health-related QoL are 
increased dependency, loss of hope, finding meaning in life and illness, concerns about death 
and unresolved guilt (Bele et al., 2012). 
 
2.3.3 Defining the QoL domains for this study 
 
As seen from the discussion above, there is no consensus about the domains of QoL, therefore 
the researcher defined the domains for the purpose of the study. The physical domain includes 
symptoms of disease and side-effects of treatment, physical functioning with regards to 
activities of daily living and the ability to take care of oneself and family members. The social 
domain encompasses personal relationships, fulfilment of roles, sexual functioning, objective 
factors such as housing and education and the ability to carry out hobbies and keep busy.  The 
emotional/psychological domain includes adjustment to illness and coping, self-esteem, body 
image, satisfaction with life, depression, anxiety and adjustment to illness. The financial domain 
includes being employed and having an income, being able to provide basic necessities and 
having money for transport. The spiritual domain encompasses spirituality/religion and 
religious practices such as prayer and attending church services, as well as existential issues 
such as hope, finding meaning and purpose in life and accepting death as part of life.  
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2.4 MEASUREMENT OF QOL   
 
The importance of measuring QoL has been emphasised by various authors. The assessment of 
QoL during clinical interviews can ensure that problem areas are addressed timeously and 
interventions are planned to improve QoL (WHO, 1997).  
The importance of assessing QoL from the perspective of the patient is highlighted by a study 
conducted in South Africa, which revealed that the severity of problems as reported by cancer 
patients was different from the severity of problems as perceived by oncology nurses (Maree, 
2011). Ferrans and Hacker, as well as Ferrell and Grant, developed conceptual models for QoL 
based on qualitative analysis of cancer patients’ perspectives and stress the importance of 
assessing QoL from the perspective of the patient (Ferrans and Hacker, 2011). An 
understanding of the impact of cancer and treatment on QoL of the patient is important in 
nursing practice.  When nurses and other clinicians understand different experiences of cancer 
and treatment, they are better equipped to assess the needs of the patient and family and care 
can be planned according to their expectations of treatment (Moore, 2007). Health care 
providers should realise that a patient’s experience is influenced by context, timing and 
personal circumstances and frequent assessments of QoL should be carried out to identify 
problems timeously.  
 
Measuring QoL has various advantages. Reasons for measuring QoL are: measurement of 
change during treatment, interaction between doctor and patient, assessment of benefits 
versus disadvantages of treatment, appraisal of the quality of health care services, research on 
the influence of diseases on QoL and the assessment of the effect of new policies on QoL of 
patients (WHO, 2005). Bele et al. (2012) agree that measurement of QoL can assess quality of 
health services and improve the relationship between the patient and health care providers, 
and state the assessment of health-related quality of life does not only provide information 
about mortality and morbidity, but also about the patient’s experience, expectations and 
overall wellbeing. 
 
QoL instruments can be described as objective means of measurement of patients’ subjective 
experiences (Hodgson and Tannock, 2005), and include three types of QoL instruments: 
generic-, disease-specific-, and symptom-specific instruments. Generic instruments are used for 
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comparisons across broad categories of illnesses and assess general aspects of QoL. The 
Medical Outcomes Short Form 36- item Health Survey is an example of such an instrument 
(Zeng et al., 2010). Disease-specific instruments are intended for the utilisation for specific 
patient groups such as cancer patients and even patients with specific types of cancers (Zeng et 
al., 2010). The European Organisation for Research and Treatment of Cancer Quality of Life 
Questionnaire (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General 
(FACT-G), for patients receiving treatment for cancer, are examples of disease-specific  
instruments (Khoshnevisan et al., 2012). Symptom-specific instruments are used for the 
measurement of symptoms and are used to determine the effect of illness and treatment on 
QoL. The McGill Pain Questionnaire and the Karnofsky Performance Index, which measures a 
patient’s ability to take care of him/herself, are examples of these instruments (Hodgson and 
Tannock, 2005, Dunn et al., 2013, Mitchell, 2001). 
 
QoL instruments usually consist of a series of items to be rated by the patient (Corner, 2008). 
For instance, the WHOQOL-BREF is a validated instrument which is a shorter version of the 
WHOQOL-100, which includes 100 questions, and comprises 26 items. The instrument was 
developed by health care providers in consultation with patients with different illnesses, well 
people and health professionals in 15 health centres around the world (WHO, 1997). This 
instrument is not cancer-specific, but assesses QoL from the perception of the patient within 
the context of his/her culture, value systems, personal goals, standards and concerns. The 
WHO’s aim was to develop a QoL instrument which could be used internationally and in 
different cultures for the measurement of health, the effects of health care and the assessment 
of personal wellbeing and QoL (WHO, 1997).  
 
QoL assessment instruments are also used to determine outcomes in cancer treatment, but not 
necessarily from the perspective of the patient’s experience of treatment. In clinical trials the 
focus is on increasing the survival rate of cancer. Current QoL instruments, such as the 
Functional Assessment of Cancer Therapy-Cervix (FACT-Cx) used for patients receiving 
treatment for cervical cancer and the Cancer Survivors’ Unmet Needs (CaSUN) used for cancer 
survivors, assess one or more of the following domains of QoL: physical-, functional-, 
emotional- and social wellbeing (Zeng et al., 2010). Physical wellbeing measures symptoms such 
as pain, nausea and vomiting, fatigue, the degree of experience of symptoms of disease, side-
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effects of treatment and other physical problems. Functional wellbeing determines the ability 
of the patient to carry out activities of daily living, such as walking, eating, taking care of 
personal hygiene, working and taking part in social activities. Emotional wellbeing identifies 
emotional or psychological problems such as anxiety or depression, while social wellbeing 
assesses aspects of social support, such as family functioning, intimacy and sexual functioning 
(Corner, 2008).  However, QoL instruments such as the Missoula-Vitas Quality of Life Index 
(MVQOLI) add existential items such as feeling disconnected, experiencing a sense of meaning 
and being prepared for death to the other domains, which includes the physical/symptoms, 
functional-and interpersonal wellbeing (Maree and Jansen van Rensburg, 2015).   
 
QoL instruments also measure quality of survival after cancer treatment, such as late physical 
and psychological consequences of treatment, and can be applied to predict the duration of 
survival from cancer. Identification of problems experienced during or after treatment and the 
management thereof is very important for the enhancement of QoL of cancer patients. QoL 
instruments can also be utilised for comparing the effects of different treatments of cancer 
(Corner, 2008).   
 
When selecting a measuring instrument, the health care provider should determine whether 
the instrument measures all aspects of QoL applicable to the patient, whether the instrument is 
validated for the population and setting of interest and whether the results obtained by the 
instrument are internally consistent and reproducible. The instrument should be sensitive 
enough to detect changes in QoL during the illness trajectory and should be easy to complete, 
score and analyse. When used for assessment of QoL of cancer patients, it is important to 
ensure that the completion of the assessment instrument does not place a high burden on a 
patient (Bennett and Closs, 2008). In addition, the importance of the cultural aspect in 
assessment of QoL of patients is stressed by Zeng et al. (2010), who suggest that if the available 
QoL instruments are not relevant for a population, an applicable instrument needs to be 
developed.  
 
Various QoL instruments have been used in cancer care. The Functional Assessment of Chronic 
Illness Therapy (FACIT) has been claimed to be one of the most popular instruments used for 
cancer patients (Fitzsimmons and Middleton, 2006) and is a general multidimensional measure 
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of health-related quality of life (Lyons et al., 2009). The FACIT was previously known as the 
FACT-G, which was developed by Cella and colleagues (Ding et al., 2012), and consists of 27 
general quality of life items. Domains included in the FACIT are: physical, social/family, 
emotional and functional wellbeing. The FACIT is usually combined with a disease-specific 
subscale such as the FACIT-Pal, which comprises 19 items, to measure quality of life of palliative 
patients. The domains of quality of life included in the FACIT-Pal are: physical, social, emotional 
and functioning (Lyons et al., 2009). Cancer-site specific sub-scales have also been developed, 
such as the FACT–Cx for cervical cancer and the FACT-O for ovarian cancer (Ding et al., 2012). 
The FACT-Lym was developed for assessing quality of life of Non-Hodgkin’s lymphoma patients. 
 
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire 
(EORTC QLQ-C30) is a generic, validated instrument for use in determining QoL in cancer 
patients. The instrument comprises 30 items, including five functional scales which measure 
physical-, role-, cognitive-, emotional- and social function; three symptom scales which rate 
fatigue, pain and nausea/vomiting; general health and QoL; single items assessing other 
symptoms specific to cancer patients such as dyspnoea, anorexia, insomnia, diarrhoea and 
constipation; as well as the financial impact of disease (Donahoe et al., 2011). As in the FACIT 
instruments, the EORTC QLQ is also combined with disease-specific subscales, such as the 
EORTC QLQ-BN20, which is a questionnaire used for brain cancer patients. The EORTC QLQ-
BN20 comprises 20 items and four scales which test future uncertainty, visual disorder, motor 
function, communication deficit and seven symptoms: headaches, seizures, drowsiness, hair 
loss, itchy skin, weakness of the legs and bladder control (Khoshnevisan et al., 2012). The 
EORTC QLQ-Cx24 is suitable for use in cervical cancer patients (Zeng et al., 2010) and the EORTC 
QLQ-OES18 for patients with oesophageal cancer (Albers et al., 2010). 
 
Established instruments for the measurement of QoL measure predetermined aspects of QoL. 
Corner (2008) warns that standardised QoL measures with fixed questions, which do not 
include a subjective aspect, may be appropriate for specific groups or specific domains, but not 
for the assessment of QoL in individuals, as patients do not necessarily regard specific aspects 
of QoL as equally important. Thus, QoL assessment instruments developed in first-world 
countries are not necessarily appropriate for cancer patients in third-world countries, such as 
sub-Saharan Africa. A patient’s experience of a symptom such as pain is influenced by 
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psychological and social factors and is often very different from the objective assessment of a 
health care professional (Bennett and Closs, 2008). The subjective experience of QoL of the 
patient always needs to be taken into consideration, especially the cultural background of the 
patient. Combining an established instrument with a subjective assessment of QoL will result in 
a better understanding of the difficulties faced by individual patients (Corner, 2008). 
 
2.5 SUMMARY 
 
Chapter 2 presented the literature review. Cancer as a world-wide health problem was 
discussed, followed by a discussion of QoL and the measurement of QoL. In Chapter 3, the 
research methods will be presented. 
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CHAPTER 3 
 
RESEARCH METHODS OF PHASE 1 
 
3.1 INTRODUCTION 
 
Chapter 2 presented a literature review. In Chapter 3, the research methods for Phase 1 of the 
study will be discussed. In Phase 1, QoL was explored from the perspective of cancer patients in 
South Africa who access public health care for treatment. The research setting will be discussed 
first, followed by the research design, the population, data gathering and data analysis will be 
explained and the principles followed to ensure trustworthiness and ethical research will be 
discussed. 
 
3.2 RESEARCH SETTING 
 
The setting, also referred to as the context, is critical for the understanding of the findings of 
qualitative research and implies the physical, geographic, temporal, historic, cultural and 
aesthetic aspects of the place where the research is conducted (Patton, 2002). Burns and Grove 
(2009) support Patton’s description of the setting and its importance and add that climate, 
home, health care system and community setting, the social setting and individual variables are 
environmental factors that can have an influence on the outcomes of a study. The setting 
selected for the study was an academic hospital in the Gauteng Province in South Africa, which 
forms part of the public health services, providing cost-free health care services to patients in 
Gauteng and surrounding provinces. The health service provided by the hospital is funded by 
the Gauteng Department of Health, as well as a National Tertiary Services Grant. The hospital 
has 1088 beds, more than 4000 staff members and provides health services to people living in 
South Africa, as well as patients from outside South Africa. The hospital provides specialised 
services to cancer patients including surgery, radiotherapy and chemotherapy on an outpatient- 
and inpatient basis.  
 
In addition, this hospital is the main teaching hospital for one of the universities in 
Johannesburg. Under- and post-graduate training is done in all areas of health professions. The 
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Department of Radiation Oncology offers external beam radiotherapy, brachytherapy and 
radio-chemotherapy to patients and treats more than 3500 patients per year (Wikipedia, 2015). 
Patients who make use of public health services are mostly from low income communities and 
do not have health insurance (SouthAfrica.info, 2015). 
 
3.3 RESEARCH DESIGN   
 
An exploratory qualitative design was selected for Phase 1 of the study.  Exploratory work is 
done when no other studies have been done in the area of interest or no definite answer exists, 
despite previous studies on the topic. Exploratory research begins with a phenomenon of 
interest, of which the full nature and related factors are investigated (Polit and Beck, 2008, 
Begley, 2008). Qualitative research methods are used to find out what people do, know, think 
and feel by observing, interviewing and analysing documents (Patton, 2002; Cresswell, 2014). In 
qualitative research, the researcher focuses on aspects such as meaning, experience and 
understanding, and does not focus on specific concepts or his/her own interpretation of events 
and circumstances. Words are used rather than numbers and data are collected in the natural 
setting of participants. The qualitative researcher does not attempt to control the context of 
the research, but attempts to capture the context as a whole. Subjectivity is essential for the 
understanding of the human experience (Brink, 2006). In qualitative research data analysis is 
done inductively and meaning is generated from the data. The researcher interprets the data 
and themes emerge from the analysis (Cresswell, 2014). The researcher chose a qualitative 
exploratory design as it allowed her to conduct an in-depth exploration of what QoL means to 
cancer patients using holistic enquiry (Patton, 2002). 
 
3.4 POPULATION AND SAMPLING 
 
In this study, the population was cancer patients in South Africa who access public health 
services for treatment. The target population differs from the population and according to Polit 
and Beck (2008), is the total set of people about which the researcher would like to generalise 
the findings. The target population has to meet specific criteria, but may still be too large for a 
study. Therefore, due to time, money and personnel constraints, the accessible population, 
which is available and meets the criteria of the target population, is used (LoBiondo-Wood and 
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Haber, 2010). The target population for this study was cancer patients receiving chemotherapy, 
radiotherapy or both at a public health care facility in the Gauteng Province. Inclusion criteria 
for the accessible population were: 18 years and older, receiving radiotherapy, chemotherapy 
or both, and willing to participate in the study.   
 
Sampling is the selection of a portion of the population to represent the population so that 
conclusions can be made about the population (Polit and Beck, 2008). In this study purposive 
and convenience sampling was used, which is a method which can be used by a researcher who 
has enough knowledge about the population to enable him/her to choose participants to be 
included in the sample. Purposive sampling is often used in qualitative research, where the 
researcher selects subjects who are typical of the population (LoBiondo-Wood and Haber, 
2010). Convenience sampling implies choosing participants who are available on the days when 
data gathering takes place and meet the inclusion criteria. In this study, the researcher included 
participants who received anti-cancer treatment for different types of cancer, represented 
different cultural groups in South Africa, were of both male and female gender and lived in both 
rural and urban communities.  
 
3.5 DATA GATHERING  
 
Patients who attended the oncology clinics in the Department of Radiation Oncology were 
recruited to participate in the study. Twenty-six participants were recruited and two refused.  
 
Qualitative interviews were used to gather the data, as qualitative interviews are the most 
effective way of obtaining information from participants about what they think, feel and 
believe (Quinne and Clare, 2008). In addition, qualitative interviews have the benefit of 
allowing the researcher to follow up on interesting topics emerging from the interview, as well 
as to ensure that all key areas are addressed. Demographic data were gathered first by means 
of a pre-interview questionnaire (Addendum A) and a topic guide (Addendum B) was used to 
guide the interviews. The findings of a previous study on QoL, from the perspective of palliative 
patients (Jansen van Rensburg, 2011), guided the researcher in compiling the topic guide.  
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Two initial questions were asked: What makes life hard for you? (Addendum G) and What 
makes life good for you? (Addendum H). Probes and prompting question were used to facilitate 
an in depth discussion, explore sensitive topics introduced by the participants and to clarify 
issues (Tong et al., 2007). The interviews were conducted by the researcher, who has been an 
oncology nurse for more than 10 years and has been practicing in the field of cancer and 
palliative care nursing for the past five years. In addition, the researcher had conducted 
interviews at the oncology clinics for research purposes prior to the current study and was able 
to establish a rapport with the participants. During the interviews, enough time was allowed for 
the researcher and participants to reflect on the issues raised. The input of the researcher is 
very important and the qualitative researcher is a research tool who, through reflexivity, is vital 
for the conduct of the research (Thompson and Baker, 2008). The interviews took place during 
February and March 2013.  
 
The first interview was used as a pre-test, to determine whether the desired information could 
be obtained during the interview and whether the audiotape worked correctly. (The typed 
transcription of Interview 1 was included as Addendum J). The first participant was reluctant to 
talk and was asked to choose a pseudonym to ensure confidentiality. Choosing a pseudonym 
had the desired effect and encouraged the participant to talk about her experience freely. The 
rest of the participants were also asked to choose pseudonyms to facilitate in depth 
discussions. Data saturation was reached after 20 interviews and two more interviews were 
conducted to ensure redundancy. This implied that the same topics emerged during 
consecutive interviews, as saturation of data is achieved when further interviews yield no new 
information (Polit and Beck, 2008). 
 
Data gathering was planned as follows: 
 
Approval was obtained from the Department of Nursing Education, the School of Therapeutic 
Sciences Research Assessor Group and the Ethics Committee of the University of the 
Witwatersrand and the Department of Health of Gauteng. The Chief Executive Officer of the 
hospital where the study took place also approved the application to conduct the research 
(Addendum C).   
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Interpreters, who were conversant in English and African languages, were used to assist with 
language issues should they arise. A confidentiality agreement was signed by the interpreters 
before the interviews (Addendum D). Interpreters were used during two interviews. Before 
conducting an interview, the researcher introduced herself and allowed time for the participant 
to introduce him/herself, in order to establish a trusting relationship before posing the research 
questions. Informed consent was obtained before the interviews (Addendum E). 
 
Consent was obtained for the use of a voice recorder during the interviews, which none of the 
participants refused. The researcher also made use of field notes during the interviews. 
Interviews were conducted in a private room, as arranged with the unit manager in charge of 
the clinics at the Department of Radiation Oncology, to ensure confidentiality and privacy. An 
hour was allocated for each interview. The researcher, who is an oncology nurse, conducted 
the interviews and only she and the participants, and where necessary an interpreter, were 
present during the interviews. Participants were reassured that they could stop the interview if 
they became emotionally or physically distressed and that the interview could be interrupted 
for a while or rescheduled. Arrangements were made for counselling, should a participant need 
counselling. None of the participants needed counselling during the interviews. The researcher 
emphasised the principle of confidentiality, by explaining that the participants’ names would 
not appear on any forms, nor would they be mentioned in the research report. 
 
3.6 DATA ANALYSIS 
 
Data analysis was done concurrently with data gathering, in order to determine when data 
saturation occurred. The researcher transcribed each interview verbatim and used Patton’s 
(2002) method of content analysis to analyse the data.  
 
The data were analysed according to the two questions asked during the interview; factors 
which had a positive influence on QoL (what makes life good) and factors that had a negative 
influence on QoL (what makes life hard). During the analysis, the researcher read through the 
field notes and verbatim transcriptions of the interviews and made comments in the margin 
about concepts which emerged. The comments were organised into topics by looking at what 
was important and describing them. A new reading was done to start coding the data in a 
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systematic way. Several readings of the data were done for complete coding of field notes and 
interviews. Topics which fit together were sorted into themes and categories. The process was 
continued until no new categories emerged and until all sources of information had been 
exhausted. The data were co-coded by the two study supervisors and a meeting was held to 
discuss the themes and categories.  
 
After the open coding, template analysis was done. Polit and Beck (2008) explain template 
analysis as a method where the researcher develops a template or guide to which narrative 
data are applied. The template was based on the domains of QoL outlined by the literature: 
physical-, psychological/emotional-, social-, financial-, spiritual- and existential factors.  
 
3.7 TRUSTWORTHINESS 
 
Trustworthiness confirmed the rigor of the study. Trustworthiness refers to the confidence 
which qualitative researchers have in their data, which is assessed by means of certain criteria 
(Polit and Beck, 2008). One way of ensuring trustworthiness is by means of narratives to display 
the richness of the data and the relationship between the themes and the quotes from the 
interviews (Streubert, 2010). 
 
The four criteria of Lincoln and Guba for trustworthiness: credibility, dependability, 
transferability and confirmability, are still regarded as appropriate for ensuring rigor of 
qualitative research (Shenton, 2004, Barroso, 2010).  
 
3.7.1 Credibility 
 
Credibility involves conducting the study in a way which enhances the believability of the 
findings and taking steps to demonstrate credibility to external readers (Patton, 2002). 
Qualifications and experience of the researcher are relevant in establishing confidence in the 
data (Polit and Beck, 2008). Credibility in qualitative research can be compared to internal 
validity in quantitative research (Polit and Beck, 2008). As guided by Shenton (2004), credibility 
of the findings of the research was enhanced by using well established research methods, for 
instance during data gathering and data analysis, and through prolonged engagement between 
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the researcher and participants. This approach fostered a trusting relationship and 
understanding. Triangulation of data improves credibility of the research. Burns and Grove 
(2009) define triangulation as “the combined use of two or more theories, methods, data 
sources, investigators, or analysis methods in the study of the same phenomenon” *p231+.  
Triangulation of data implies the collection of data from multiple sources to capture different 
experiences of an event. Triangulation of investigator is achieved when more than one 
investigator with different expertise examine the same phenomenon. Analysis triangulation 
takes place when the researcher uses two or more analysis techniques (Burns and Grove, 
2009). In this study data were collected from 22 participants treated for different cancers, who 
were of different genders, ages and cultural groups. Two methods and three investigators with 
different backgrounds analysed the data. 
 
Shenton (2004) also adds that ways should be devised to ensure honesty in participants by not 
forcing anybody to participate in the study and encouraging participants to talk freely. In this 
study, honesty of responses by the participants was enhanced by giving participants the choice 
whether to participate in the study or not. Allowing participants to choose a pseudonym for the 
interview reassured them that they could talk freely and that their identities would not be 
disclosed. Participants were informed that they could withdraw from participating in the study 
without any negative consequences to them. During the interviews probing questions were 
used and questions were rephrased when answers were not sufficiently clear to elicit detailed 
and truthful data, as supported by Shenton (2004). Lincoln and Guba, as quoted by Shenton 
(2004), mention member checks as an important aspect in ensuring the accuracy of the data. 
Polit and Beck (2008) explain member checks as a method used to validate the credibility of 
qualitative data by means of discussing data with the participants. Although the transcribed 
interviews were not given to the participants to read, the researcher used questions such as 
“do I understand you correctly” during the interviews and summarised the interviews as 
member checks. 
 
Thick description is another way of ensuring credibility and is defined by Polit and Beck (2008) 
as “a rich and thorough description of the research context in a qualitative study” *768+. The 
research setting was discussed in detail in the study.  
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Researcher credibility must be verifiable by other researchers in order to have faith in the 
credibility of the data, as qualitative researchers, according to Polit and Beck (2008), are “data 
collecting instruments and creators of the analytic process” *550+.  The researcher is a post-
graduate student who completed her Masters’ degree in Nursing in 2011. Prolonged 
engagement in the field was achieved by the researcher being qualified as an oncology nurse 
since 2004 and having practiced in an oncology care setting for the past five years. The 
researcher became acquainted with the study population during previous data gathering at the 
oncology clinic as a research assistant in 2012. 
 
Shenton (2004) suggests that credibility of the research can be enhanced further by frequent 
collaboration between the researcher and supervisors to widen the vision of the researcher and 
identify errors and biases. Frequent meetings took place between the researcher and her study 
supervisors to discuss the data analysis and findings. Peer review is also mentioned as a method 
to ensure credibility, as well as feedback given during presentation of the research at 
conferences. The research proposal was subjected to peer review, as both the members of the 
Department of Nursing Education as well as the PhD Assessors Committee of the Faculty of 
Health Sciences critiqued and approved the proposal. The research was presented at an 
oncology conference and feedback was received.  
 
3.7.2 Dependability 
 
Dependability of research refers to stability and reliability of data over time, comparable to 
reliability of quantitative research, to ensure integrity in qualitative research (Polit and Beck, 
2008). According to Shenton (2004) dependability can be enhanced by describing the research 
processes in detail, to enable other researchers to repeat the work and obtain the same results. 
Lincoln and Guba, as quoted in Polit and Beck (2008), mention that credibility is linked to 
dependability and one is not valid without the other. In this study, the research process was 
described as thoroughly as possible. By developing a research proposal and describing the 
research design and how the study would be implemented also enhanced dependability.  
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3.7.3 Transferability 
 
Transferability in qualitative research can be described as the possibility of transferring the data 
to another setting and is achieved by means of thick description of the research context and 
setting (Polit and Beck, 2008). Shenton (2004) mentions that the qualitative researcher cannot 
claim that the research is transferable, but describing the setting and research process as 
comprehensibly as possible, would allow readers to determine whether the study could be 
repeated in another setting. In this study, the setting where the data gathering was done was 
described in detail. 
 
3.7.4 Confirmability 
 
Confirmability refers to objectivity, or congruence between two or more independent people 
about the accuracy, relevance and interpretation of the data (Polit and Beck, 2008). According 
to Shenton (2004), confirmability is achieved when the findings of the research are obtained 
from the experiences and ideas of the participants and are not biased by the researcher’s 
preferences. Confirmability is also enhanced by means of triangulation and a detailed 
description of the research methodology. In this study, the completeness of the research 
proposal was assessed by the supervisors and the proposal was subjected to peer review. 
 
The findings were based on raw data. Applicable themes and categories were identified by 
following Patton’s (2002) approach in analysing data. An audit trail was developed to provide 
evidence that the findings were grounded in the data. An audit trail is a systematic collection of 
documentation, that allows an independent auditor to come to conclusions about the data by 
tracing the research step-by-step (Polit and Beck, 2008, Shenton, 2004). Records which were 
included in the audit trail were the transcribed interviews, field notes, data analysis products, 
process notes and data construction products, such as drafts of the final report. 
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3.8 ETHICAL PRINCIPLES 
 
The ethical principles outlined by Haigh (2008) were applied in the study: autonomy, 
beneficence, informed consent, non-maleficence and dissemination of results.  
 
3.8.1 Autonomy 
 
Autonomy of participants in a study implies that the final decision whether to participate in the 
study lies with the participants (Burns and Grove, 2009). The participants’ right to self-
determination was respected and participation in the study was entirely voluntary. The 
researcher explained to the participants that they could refuse to participate, or withdraw, at 
any stage during the interviews without any consequences to them. 
 
3.8.2 Beneficence 
 
Beneficence implies the obligation of the researcher to promote good, which is the opposite of 
non-maleficence, where the researcher is under obligation not to do harm (Burns and Grove, 
2009). The researcher explained to the participants that she wished to understand what was 
important to them in terms of QoL and what impacted negatively on their QoL, in order to 
develop an appropriate QoL assessment instrument for cancer patients in South Africa.  
 
3.8.3 Informed consent 
 
After explaining the study and the participants’ rights, written consent was obtained from the 
participants (Addendum E). 
 
3.8.4 Non-maleficence 
 
Participants were not forced to disclose information and all information was given to the 
researcher voluntarily. Participants were selected for reasons directly related to the problem 
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being studied and were treated respectfully and courteously at all times. Participants were 
reassured that the interviews could be interrupted or postponed in case of physical or 
emotional distress during the qualitative interviews. The principle of non-maleficence also 
applies to data gathered (Haigh, 2008). Participants’ identities were protected at all times by 
omitting their names on forms and by using pseudonyms during interviews. Permission was 
asked for the use of a voice recorder during the interviews and none of the participants 
refused. Participants were reassured that the data would only be discussed with the study 
supervisors and that their names would not be mentioned, to protect their identities. Privacy 
was ensured by conducting the interviews in a private room.   
 
3.8.5 Dissemination of findings 
 
Non-maleficence is also applicable to the dissemination of the findings of the study, especially 
with regards to confidentiality and protecting personal characteristics of the participants 
(Haigh, 2008). When publishing the research findings, the participants’ identities will be 
protected. The findings will be published in peer reviewed journals and will be presented at a 
national and international conference. 
 
3.9 SUMMARY 
 
The research methods for Phase 1 of the study were discussed in Chapter 3. The research 
setting was discussed in detail, followed by the research design, population and sampling, data 
gathering and data analysis. Measures taken to ensure trustworthiness were discussed, as well 
as ethical principles which guided the research. Chapter 4 will present the findings and 
discussion of Phase 1. 
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CHAPTER 4 
 
FINDINGS AND DISCUSSION OF PHASE 1  
 
4.1 INTRODUCTION 
 
In Chapter 3, the research methods for Phase 1 were discussed. Chapter 4 will present and 
discuss the findings of Phase 1 of the study. Pseudonyms will be used when presenting the 
findings. The demographic data will be presented first; the themes and categories will then be 
described, followed by the discussion of the findings. 
 
4.2 PARTICIPANTS 
 
The sample for the first phase of the study consisted of 22 participants (n=22), all of whom 
were given pseudonyms to protect their identities. Saturation of data was achieved after 20 
interviews but two more interviews were conducted with participants treated for different 
cancers to ensure saturation. The first interview served as a pre-test to test the topic guide and 
audiotape. The ages of the participants ranged from 20 to 79 years, with the majority being 
between 40 and 69 years. Both genders were represented, but most (14 of 22) of the 
participants were female. Most of the participants were Black, representing seven different 
cultural groups, with the other participants being Caucasian, Coloured (mixed race) and Asian. 
The demographic data are presented in Table 4.1 on page 34. 
 
4.3 THEMES AND CATEGORIES ARISING FROM THE DATA 
 
As already mentioned in section 3.6, the data from the in-depth interviews were analysed 
according to factors which had a positive and negative influence on quality of life. 
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Table 4.1: Demographic data of participants (n=22) 
 
Pseudonym  Age  Diagnosis  
Treatment 
received 
Cultural group  Educational level 
Poppy 28 Cervical cancer Brachytherapy Sesotho Grade 11 
Mammy 44 Cervical cancer Radiation Zulu Grade 11 
Thabo 69 Breast cancer Radiation Tswana Grade 8 
Peace 44 Breast cancer Chemo-
radiation 
Xhosa Tertiary 
Pieter 74 Prostate cancer Chemo-
radiation 
Caucasian Grade 10 
Peter 63 Prostate cancer Radiation Tswana Grade 10 
Joseph 64 Prostate cancer Radiation Zulu Grade 7 
Mapule 56 Cervical cancer Radiation Sesotho Grade 12 
Oprah 39 Cervical cancer Chemo-
radiation 
Zulu Grade 10 
Steve 54 Prostate cancer Chemo-
radiation 
Sepedi Grade 12 
Doctor 39 Kaposi sarcoma Chemo-
radiation 
Zulu Grade 8 
Martjie 62 Ovarian cancer Radiation Coloured No formal 
education 
Elvis 26 Kaposi sarcoma Radiation Tsonga Grade 12 
Busie 41 Cervical cancer Radiation Zulu Grade 11 
Harriet 49 Cervical cancer Radiation Congolese Tertiary 
Sam 56 Kaposi sarcoma Chemotherapy Xhosa Tertiary 
Nicole 33 Breast cancer Chemo-
radiation 
Zulu Grade 12 
Cindy 55 Breast cancer Chemo-
radiation-
surgery 
Malayan Grade 12 
Delilah 62 Rectal cancer Chemo-
radiation 
Sesotho Grade 3 
Sandy 46 Cervical cancer Chemo-
radiation 
Caucasian Grade 12 
Petrus 50 Stomach cancer Chemo-surgical Tswana Grade 3 
Nomsa 40 Head and Neck 
cancer 
Radiation Xhosa Grade 8 
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The themes and categories identified during data analysis were summarised in Table 4.2. 
 
Table 4.2: Themes and categories 
 
Themes 
Categories 
Factors which had a positive 
influence on quality of life 
Factors which had a negative 
influence on quality of life 
Social aspects of QoL Being with other people. 
 
Support of family, friends and 
church members. 
 
A safe, clean place to stay, food, 
transport 
Role changes. 
 
Being separated from children 
and family for long periods. 
 
Difficulty with transport to the 
hospital. 
 
 
Lack of employment and income. 
 
Inability to support the family. 
 
Boredom due to lack of money 
for hobbies. 
Physical Ability to carry out household 
tasks and stay busy. 
 
 
Ability to take care of 
him/herself. 
Stable body weight. 
 
Symptom control. 
Side-effects of cancer and 
treatment. 
 
Symptoms: anorexia, weight loss, 
nausea and vomiting, diarrhoea, 
fatigue, stomach cramps, pain, 
dizziness, joint pain, alopecia, 
skin discoloration, hot flushes, 
memory loss, sexual dysfunction, 
visual disturbances, bleeding, 
insomnia, poor body image. 
Spiritual Spiritual growth. 
 
Stronger relationship with God. 
 
Hope of eternal life. 
 
Relationships with church 
members. 
Difficulty praying. 
 
Not being able to take part in 
religious activities. 
 
Not being able to attend church 
services. 
Financial Having a regular income. 
 
 
Debt incurred to pay for 
transport. 
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Themes 
Categories 
Factors which had a positive 
influence on quality of life 
Factors which had a negative 
influence on quality of life 
Being able to support him-
/herself and family.  
Having to use money from 
provident fund. 
 
Defaulting on treatment to go 
back to work. 
 
Not being able to buy “healthy 
foods” prescribed by the 
dietician. 
 
Having to use the child support 
grant for transport. 
 
Not having money for food. 
 
Being financially dependent on 
family members. 
Existential Opportunity for learning and 
growing. 
 
Supporting others in the same 
situation. 
 
Focusing on the future. 
 
Accepting death as part of life. 
Not being able to make long term 
plans. 
Emotional Resilience: acceptance of 
diagnosis and treatment. 
 
Positive attitude. 
 
Gratitude for treatment and 
caring health professionals. 
Life is difficult and challenging. 
 
Fear of treatment and weight 
loss. 
 
Anger and frustration about 
inability to carry out household 
tasks. 
 
Feeling overwhelmed by illness 
and responsibilities. 
 
Stress caused by lack of income. 
 
Embarrassment about 
symptoms. 
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Themes 
Categories 
Factors which had a positive 
influence on quality of life 
Factors which had a negative 
influence on quality of life 
 
Depression. 
 
Sadness due to poor body image. 
 
Confusion about mixed 
messages. 
 
4.3.1 Theme 1: Social aspects of QoL 
 
Being supported by a spouse, family, friends and church members and having their company 
enhanced the QoL of the participants, as they were able to talk to them and share their 
experiences. Peter explained: “I’m always enjoyed with somebody, got my daughter, 
granddaughter…I like to socialise with my neighbours, go to church.” Oprah added: “There is 
this sister of mine from the church…I’m calling her my sister, because she’s been like a sister to 
me. I can talk to her.” Doctor said: “What I can say…it’s my wife, because she always is there 
and always if I want to speak with somebody, my wife is there…” 
 
In contrast, being separated from their family during treatment caused emotional distress for 
many of the participants. Participants were not only worried about the treatment they were 
receiving, but also about who would care for their children at home. Participants with small 
children had the additional burden of having to manage the separation anxiety of their 
children. Thabo explained: “I left my daughter there at home, I came to the hospital. I did not 
have a choice… Now I worry about the treatment, I worry about my daughter and her child… 
what are they going to eat?” Busie added: “They (small children) say ‘Mama, please don’t go, 
wait for me… don’t go there, wait for me, because I’m not sure are you going to die or not, so 
wait for me’ and when I phoned the children, the youngest one said ‘Mama, when do you come 
back? Are you going to die there?’”  
 
Transport between their homes and the hospital was a major problem for the participants. 
Some had to get up very early to drive to the hospital, whilst others had to use public transport, 
which was cumbersome, exhausting and costly, to get to the hospital. Pieter said: “We stay far 
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from here. I stay in another province. When we have finished here we drive home, more than a 
hundred kilometres. Tomorrow morning I have to leave at four o’clock. That is very hard for 
me.” Peace added:  “I’m taking a train from Tembisa to Kempton Park, then, from Kempton 
Park I take a taxi to Jo’burg. From Jo’burg I take another taxi here (hospital) and going back 
every day… for the whole month I have to do that…”  
 
Affordable, safe and clean accommodation and transport whilst receiving treatment added to 
the quality of life of the participants, especially those who had no income and had to travel far 
to the hospital. Thabo explained: “… the home was only R40-00 per week, then we sleep at the 
home and the transport bring us here. That made also my life easier, you see… and the food also 
was very nice at the home…it was a nice place. An old age home, it was a very nice place, very 
clean. The food also was very nice. Where we sleep the blankets were very nice. That also made 
our lives better.” 
 
Cancer caused role changes and deprived the participants from being breadwinners, part of the 
workforce and sex partners. In addition, some also lost their role as spouse and had to become 
the strong one in the family. Poppy explained: “It didn’t change. I played all my roles well, 
except the girlfriend part, then there was no sex anymore…and I feel it’s unfair to him, that it’s 
been months now…I feel inside I’m depriving him of that.” 
 
Harriet added:  “It’s painful for them. Since they told me I’ve got cancer, the house is quiet. I 
know it’s painful, even for my husband, but I must be strong. I’m a woman… I must help my 
family to be strong… they can’t lie down because of me…” 
 
Not receiving a salary or wage forced some participants to use the social support grants 
allocated to their children, or having to ask family members for financial support. Additionally, 
some participants depleted their sick leave, whilst others who were working in the informal 
sector still had to try to keep working to provide for their families. Doctor explained: “Always I 
do my things, like I know every day I go to work, on Friday end of month I’ve got my pay… but 
now I’m suffer to get that things I need, because I’m not working…I must ask my mother, my 
father and my kids the grant… my life had changed like that…” 
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4.3.2 Theme 2: Physical aspects of QoL 
 
Being physically strong enough to be able to work, carry out normal household tasks and take 
care of him/herself was an important aspect of QoL, not only did it allow participants to earn an 
income, but also kept them busy. Thabo said: “I enjoy cleaning my house, doing my own 
washing with my own hands… since this cancer, I am going to enjoy things more… To do things 
for yourself is better than to lie there…” Busie added: “The thing that make life good for me is if 
I’m working, like I say I’m sewing, getting money, feeding my children… to do things for myself.” 
 
In contrast, the physical sequellae of cancer and its treatment influenced the QoL of the 
participants negatively. Fatigue made it hard to carry out household tasks and to engage in paid 
work. Participants were of the opinion that their bodies were drawing them back and they 
couldn’t do what they wanted. Oprah said: “Since I’m on chemo, I’m always weak, always sickly, 
like a zombie or something. I don’t know how to describe it, but the department where I work, 
you are supposed to be energetic and fun to be around… We work long hours, thirteen plus 
hours… maximum fourteen…” 
 
Maintaining their body weight was important to the participants and added to their QoL. Poppy 
explained what made life good for her:  “It’s a stable body… I don’t like to lose weight…being 
thin, thin, thin….”  Weight loss led to a poor body image, embarrassed participants and 
suggested, to them, that they would not get better and were going to die. Busie said: “I feel 
bad. It’s not nice, because I can’t even walk in front of people. Now I’m hiding myself… I’m not 
going around, because people say ‘oh, Busie, you’re so slim’, you know. So I don’t want this 
shame, shame thing… It’s like I’m going to die, you see… It’s like…I won’t get better… I don’t 
even believe that I’ll be okay… I don’t know the way forward…” 
 
Pain had a negative influence on the QoL of the participants and good symptom control was 
important. Steve said:  “If you haven’t got pains that day, it’s a big happy day…”  In addition, 
symptoms such as anorexia, nausea and vomiting, diarrhoea and stomach cramps also had a 
negative influence on QoL. Poppy said:  “I lost weight, vomited, loss of appetite… that’s how it 
affected me… and diarrhoea also…. It was not easy, but… I thought I was strong… but it was not 
easy, not easy at all…”  Alopecia and hyperpigmentation were of great concern to some of the 
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participants. Peace explained:  “You know, yes you lose hair, and you look strange. My colour 
was…I was so dark, dark, dark. I was so dark…you know…I was, even though I was pressing on, 
but you don’t feel like being in an environment where there are people who would just keep on 
asking you ‘hey, why did you cut (your hair), what’s happening, what did you put on your face?’” 
 
Sexual function changes led to a decrease in QoL. Some participants were acutely aware of 
these changes and how it affected the relationship with their partners. Cindy said: “When I 
started the cancer and then my sex life was not the same. When you’re busy with chemo, your 
vagina is very dry, completely dry… and husbands don’t like it to be dry. Also I know when you 
go to the toilet all the chemo that gush out and you always have that smell on you… he didn’t 
like that (Cindy).” 
 
4.3.3 Theme 3: Spiritual factors influencing QoL 
 
Spirituality played an important role in the lives of the participants and in their QoL. Prayer and 
being able to go to church was important to many of the participants, as it meant being 
accepted for what they are, and being accepted reduced their stress levels. Having cancer led to 
spiritual growth and a closer relationship with God for most. Thabo said: “You know how it is, 
when you are in difficulty, that is when you think more of God than when you are not sick. You 
speak to God more than when you are not sick, you feel nearer to God.” 
 
Peace added:  “First of all, I am a child of God. Prayer makes life good for me, and the love, 
peace, honesty, forgiveness and my work. When it comes to spiritual life, you know, it took me 
to a higher level. Instead of feeling like wow, there’s no God, then, you know, when it comes to 
that, it really made me to be strong. It made me to come close to God, it made me appreciate 
God more than before.”  
 
Some participants had problems with their spiritual lives and having cancer and being treated 
hindered them from praying and taking part in religious practices. Busie explained:  “The 
problem is when I’m praying… maybe I’ll only say two or three words, then I’ll cut…I don’t know 
why.” 
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A Muslim woman was unable to fast during Ramadan due to the fact she was “unclean,” as she 
could not wash her whole body with soap and water because of the radiation. She was weak 
because of chemotherapy and therefore could not cook and bake as she usually did during the 
fasting period. She was also not allowed to pray on the special mat due to being regarded as 
“unclean.”  Cindy said:  “In this month you must give to the poor and you must pray, like at the 
moment I can’t… we got our mat which is called a Masala, now at the present moment I can’t 
even get onto that Masala, because I’m not clean, I can’t touch the Koran, our Bible, because 
I’m not clean…” 
 
Believing in God resulted in feeling safe and protected and gave participants the opportunity 
and courage to continue their lives and get their lives in order. Petrus explained: “…so I just 
pray, I give everything to God…it’s up to You what’s happening to me. I ask Him to protect me.” 
Sandy added: “I took it as a blessing, because I had a second chance to get my life in order…I 
talk to my children and my friends and everybody… we must get closer to the Lord, because that 
is your only solution.”  
 
Hope played an important role in the QoL of the participants. Having faith gave many hope and 
the courage to go on with their lives. Steve explained how faith gave him hope, “At present it’s 
a bit special thing, because I’m a Christian. Then I’m hoping to get the better life in future, 
because now we can struggle there and there, but in future I’m hoping to get the better life. 
Even if I die now, the resurrection is there, and then that’s my hope, that’s what makes me 
happy, even if I’m sick. It gives me peace.” 
 
4.3.4 Theme 4: Financial factors that influence QoL 
 
Financial problems had the greatest influence on the QoL of the participants. Apart from having 
to cope with cancer and its treatment, most of the participants struggled to survive without an 
income, living only on old age pensions, disability grants and child support grants.  The cost of 
transport played a major role in participants’ financial difficulties and many were unable to 
afford the necessary nutritional food. Thabo said: “At the moment, what made my life bad… 
where I stay is a bond house. Now I must pay electricity, water, food. My daughter is not 
working… now I worry about my daughter and her child… what are they going to eat?” Poppy 
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explained: “My mother is not working, nobody is working at home so we don’t get, like, 
nutritious food… you know, for me to eat to keep fit. When I had chemo, I had to eat healthy 
food, but I could not as there was no money and we had to spare money for transport also.” 
 
Some participants became financially dependent on family members, which was hard for many 
of them. Sandy described: “…I’m used to being independent, and I don’t like to stand with my 
hand the whole time… When I, on the spur of the moment, want to eat a chocolate, I don’t want 
to say ‘Hey, please give me ten rand, I want to buy a chocolate’… you know what I mean…”  
 
Having a regular income enhanced the QoL of the participants. Some participants were 
employed, whilst others had a business or received financial support from children and family 
members. Not only did a regular income allow participants to care for their daily needs, but also 
gave them a sense of self-worth. Nicole said:  “My work makes me feel good, the people I’m 
working for… I started sewing and sewing and I’m selling all that. Just makes me feel good to 
look at what I’m doing with my own hands…just comes perfect and I sell to people. That’s self-
support. I’m not short of money, because of all that.” Steve added: “Yes, yes we manage with 
the finance. Ja, everything is still going fine at home, because the government helped us with 
the free medication and treatment we get from the hospital. So it makes us easy even if you 
haven’t got that big business you can still survive. So I haven’t got a problem financial at home.” 
 
4.3.5 Theme 5: Existential factors influencing QoL 
 
Some of the participants regarded the experience of cancer as an opportunity for learning and 
growing, while others experienced it negatively because they could not make long term plans. 
Oprah said: “I have actually grown since I’ve known that I’ve got cancer, because now, on top of 
everything, I now respect people who tell their stories about cancer and I now listen. I never 
used to… but now I pay attention and I…I would like to be more of an involved person…now I 
want to grow deeper, to knowing the people. I think after I go through this phase, I will be able 
to empower two, three people in my life with this phase I’ve gone through.” Steve said:  
“Everything really does change when you have cancer… the thinking has changed. You feel like 
your life is shorter. You cannot plan things for five years, ten years to come… cancer it keeps you 
there…” 
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Being able to support others in the same situation gave meaning to the lives of some of the 
participants. Some also compared themselves with other patients who, according to them, 
were in a worse situation than they were, making them grateful for what they experienced. 
Peace said:  “I want to really see myself standing up strong and supporting other people… and 
to uplift and counsel them…that’s my mission, you know, that’s what I’m looking forward to 
do.” Pieter explained: “If you look at what’s going on around you, you have to say thank you.”  
 
Accepting death as part of life enhanced the QoL of some of the participants; however some 
did not want to be confronted with death and focused on the future which gave them hope.  
Nicole said: “People they tell ‘Oh, you’re going to die’ and I never wanted people like that and 
say no, this person is not right for me. I need someone who’s going to tell me that I’m going to 
be better, because I know that I was going to be better and I’m better right now.” Harriet said:  
“It’s okay, it’s life. Born one day, you can suffer and you can die. It’s life, it’s part of life.”  
 
4.3.6 Theme 6: Emotional factors influencing QoL 
 
Having to live with cancer was not easy and the participants used words such as ‘horrible’ and 
‘my life is a mess’ to describe what it was like to be diagnosed with cancer. Participants also 
feared their diagnosis, the treatment, dying and what would happen to their children after their 
death.  Doctor explained: “Now I was in the machine, I don’t know what it look like that 
machine, it was my first time to go there… I was scared, because the people they said: ‘hey, 
you’re going to burn.’” Busie added: “You know what I’m scared of? I’m scared of about the 
people who are left, because maybe I won’t feel pain, but what about the others…?” 
 
Despite the negative emotions, most of the participants accepted the diagnosis of cancer and 
the treatment and displayed resilience. They were grateful for knowing what was wrong with 
them and for the treatment they received, some even got used to the treatment. Participants 
were also grateful for being alive and for the company of other people. Nicole said: “When I 
found out that I’ve got cancer, I accepted and I told myself that I was going to be better and 
cancer was not going to ruin my life, was not going to take my life down… Another thing which 
makes me feel good, I talk… communicate with everyone… I speak to other patients…”  
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Some participants confessed to feeling angry and frustrated when they could not carry out 
household tasks due to weakness and fatigue. They felt overwhelmed and tired of taking all the 
responsibilities and felt that others were expecting too much from them. In addition, 
participants were emotionally distressed about the lack of income, weight loss and the side 
effects they were experiencing. Oprah said:  “Ah, the emotional part of this journey. I haven’t 
come to grasp with it… it’s the mood swings. I don’t know, maybe it’s me or it’s the treatment or 
is the chemo, I don’t know, but I’ve become a very moody person, an angry person…ja, don’t 
understand that. I do not understand how to handle it. It’s giving me so much pressure. On an 
emotional level I’m not so… I’m not good.” Elvis added: “Other people, if I show them, (the 
lesions on his legs) they start joking… but as they start to, I feel like I’m not a person. I feel like I 
am not a person anymore, because you feel you are sick every day. My life, it’s a mess at the 
moment.”  
 
Participants became depressed when confronted with body image changes and the sexual 
complications of their cancer.  Pieter said: “Before I got cancer, we could do something, but now 
we can’t (have sex).” He added that his breasts were tender and said he had told the doctor: 
‘You are busy making a woman out of me.’ Cindy added:  “When I look in the mirror I just don’t 
like it, honestly I don’t, and I tell my husband I’m a half woman now, I don’t have a breast…” 
 
Meeting other cancer patients and being able to talk to them allowed the participants to share 
the emotional burden of their cancer and accept their diagnosis. Thabo explained: “With the 
cancer treatment you are not alone, you meet people and you discuss…you know, and that also 
helps you to accept your cancer, because there are a lot of us…” 
 
Receiving treatment, care and support eased the emotional burden the participants had to 
bear. Peace explained:  “Luckily there is this help we are getting and what I know is all those 
things are expensive, the treatment and all that… and I really appreciate, and the environment 
also. What I’ve realised, people who are working with cancer people, they are different from 
other people… you can see there is that heart…of taking care and trying to attend us and giving 
that support.” 
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4.4 DISCUSSION 
 
To guide the discussion, the themes identifying the domains of quality of life applicable to the 
study population were compared to the FACT-G, the EORTC QLQ-C30 and the WHOQOL-BREF 
QoL instruments (Table 4.3) and only those domains not included in these instruments will be 
discussed. 
 
Table 4.3: Comparison of domains of QoL in the current study, the FACT-G, EORTC QLQ-
C30 and WHOQOL-BREF   
 
Domain 
CURRENT 
STUDY 
FACT-G EORTC QLQ-C30 WHOQOL-BREF 
Physical/functional X X X X 
Social X X X X 
Spiritual X    
Financial X  X  
Psychological    X 
Emotional X X X  
Environmental X   X 
General health   X X 
Role X  X  
Cognitive   X  
Existential X    
 
Spirituality played an important role in the QoL of the study participants and various factors, 
such as prayer and ability to attend church services, influenced the spiritual domain both 
positively and negatively. Fitzsimmons and Middleton (2006) support this finding and state that 
spiritual factors can have a positive or negative influence on the experience of cancer and the 
treatment thereof. Spiritual distress can be defined as “a state of experiencing a disturbance in 
one’s belief or value system that provides strength, hope, and meaning in life” and is often 
mistaken for psychological problems (Grimm, 2005) [p39]. Cancer patients have spiritual needs 
such as finding meaning in illness and life, a relationship with God and others and expectations 
regarding life after death (Crowley, 2005). Participants mentioned spiritual growth and a closer 
relationship with God. Faith in a spiritual world, religion and religious practices foster hope 
(Buckley, 2008), which was confirmed by participants in this study. 
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 The finding that spirituality played an important role in QoL of the study population was 
expected. In a previous study where South African patients from a resource-poor community 
were involved, spirituality was identified as an important aspect of QoL (Maree and Jansen van 
Rensburg, 2015). Several participants mentioned that the support of members of their church 
and participating in religious activities such as prayer and attending church services were 
meaningful to them.  
 
Financial factors played a major role in QoL of the participants. Having a regular income and 
being able to support themselves and their families had a positive influence on QoL of 
participants, whilst debt, being unemployed and having to depend on others and other sources 
of income influenced QoL negatively. In addition, the inability to work and provide for children 
and family members was hard for participants. Fitzsimmons and Milddleton (2006) 
acknowledge the fact that financial factors have an important influence on QoL and indicate 
that financial aspects, such as the costs of travelling, loss of income, medical costs and the cost 
of a caregiver, play a major role in QoL, especially in patients from resource-poor communities 
(Fitzsimmons and Middleton, 2006).  
 
Ferrans (2011) confirms that employment/unemployment and the ability to take care of 
financial needs are very important for QoL and Ferrell and Grant (Ferrans, 2011) recognise 
financial burden as an important aspect of QoL. The incidence of poverty in patients accessing 
public health care in South Africa is high, which aggravates their suffering when coping with 
cancer and treatment. In 2011 the unemployment rate was 24% in South Africa and 20.2% of 
South Africans lived below the food poverty line (Maree and Jansen van Rensburg, 2015). These 
findings are confirmed by a study of minority groups in the United States of America who 
experience severe poverty and food insecurity (Gany et al., 2015).  
 
Gany et al. (2015) agree that cancer patients face severe financial strain and that their financial 
and logistical needs are often not met. The authors acknowledge the fact that patients 
sometimes default on cancer treatment when they have to choose between spending their 
small income on food or medical care, as was confirmed by this study. 
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Role changes had a negative impact on QoL, especially with regards to sex, being the bread 
winner and the role of caregiver. Additionally, participants’ roles changed from being 
independent and able to care for their families to being dependent on others. Factors such as 
heavy bleeding due to cervical cancer and dryness of the vagina due to the side-effects of 
chemotherapy had a negative impact on sexuality and the role of participants as sexual 
partners. Ferrans (2011) includes sexual functioning as an important component of social 
wellbeing. A patient with prostate cancer mentioned erectile dysfunction and gynecomastia, 
which are side-effects of hormonal therapy (Nishimoto, 2005).  
 
Several participants complained about being dependent on family members due to the fact 
they were too sick to work or lost their jobs when they got cancer. Apart from not being able to 
meet financial needs, the demands of taking care of the family and household tasks while 
undergoing treatment for cancer took their toll on participants who suffered from fatigue. 
 
Existential factors include purpose and meaning in life (Searle, 2001). Maree et al. (2015) add 
religion and hope. Other existential issues which have an impact on health-related quality of life 
are increased dependency, loss of hope, finding meaning in life and illness, concerns about 
death and unresolved guilt (Bele et al., 2012). Uwimana (2005:10) supports these findings and 
describes QoL as a person’s sense of wellbeing and satisfaction with life, despite objective 
aspects such as income and physical functioning. 
 
In this study various factors played in role in the existential domain, those influencing the QoL 
of participants negatively to a greater extent than those with a positive influence. Participants 
described their experience with cancer as an opportunity for learning and growing and others 
found meaning in their circumstances by supporting other people going through the same 
experience.  
 
4.5 SUMMARY 
 
Chapter 4 presented the findings and discussion of Phase 1 of the study in view of the 
literature. The demographic data of the participants were presented and the themes and 
categories which emerged during data analysis were discussed. The data were organised 
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according to factors which had a positive and negative influence on QoL, as well as the domains 
of QoL which were used as a template during the analysis. The domains of QoL which were 
applicable to the study participants were compared to the domains included in the FACT-G, the 
EORTC QLQ-C30 and the WHOQOL-BREF. A discussion of the domains applicable to the study 
participants, but which are not included in the FACT-G, the EORTC QLQ-C30 and the WHOQOL-
BREF, followed.  
 
In Chapter 5 the methods of Phase 2 will be presented. 
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CHAPTER 5 
 
RESEARCH METHODS OF PHASE 2 
 
5.1 INTRODUCTION 
 
Chapter 4 presented the findings of Phase 1 of the study. Chapter 5 will discuss the research 
methods of Phase 2 of the study. The aim will be explained first, followed by the research 
process which was used in the development of a QoL assessment instrument for cancer 
patients in South Africa. 
 
5.2 AIM OF PHASE 2 
 
As already mentioned in Chapter 1 (1.3), the aim of Phase 2 was to develop and validate a QoL 
instrument appropriate for cancer patients in South Africa.  
 
5.3 RESEARCH DESIGN 
 
The overall design of the study was a mixed methods design. In mixed methods research, both 
qualitative and quantitative approaches are followed and the integration of the data may 
involve philosophical assumptions and theoretical frameworks (Cresswell, 2014). In Phase 1, a 
qualitative approach was followed.  
 
In Phase 2 of the study a quantitative design was used to validate the questionnaires. 
Quantitative research is applicable for the statistical analysis of numeric data for the description 
of a phenomenon (Polit and Beck, 2008).  The design is applicable for the validation of an 
instrument to ensure that the instrument reflects what it intends to measure (Adnane et al., 
2016). The questionnaires were validated by means of rigorous psychometric testing using the 
Rasch Measurement model.  
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5.4 RESEARCH PROCESS 
 
The research process will be discussed with regards to the development of the QoL instrument, 
the population, sampling and pilot testing, as well as the validation of the instrument. 
 
5.5 THE QOL INSTRUMENT 
 
The categories which emerged during analysis of the interviews conducted in Phase 1 were 
operationalised into questions and two questionnaires were compiled according to factors 
which had a negative and positive influence on QoL, as mentioned in the topic guide: 
 
Questionnaire 1: What makes life hard for you? (Addendum G) comprised 67 questions and 
Questionnaire 2: What makes life good for you? (Addendum H) comprised 50 questions.  
 
A section for demographic data of respondents was included in the questionnaires to ensure 
that all the inclusion criteria were met: different genders, cultural groups and cancers. The 
highest level of education was included to evaluate whether the questionnaires would be 
suitable for participants with different levels of education. The ages of participants were 
included in the demographical data to determine what the influence of age was on QoL. The 
demographic data gathered are summarised in Table 6.1.  
 
The guidelines of Khadka et al. (2012) were applied in the development of the questionnaires. 
The following characteristics are needed for a good rating scale or questionnaire: hierarchical 
ordering of responses from lower to higher value, unconnected categories, 
respondents/participants must understand the response categories and categories for the 
question must be appropriate. There should not be too many response categories as it causes 
confusion and respondent burden. Examples of response categories: Pain: none =1, mild =2, 
moderate =3, severe =4, very severe =5 and Yes =1, no =2, not applicable =3. 
 
Short descriptions are needed for categories and neutral categories should be avoided. Non-
overlapping categories should be created which are mutually exclusive and collectively 
exhaustive and conceptually overlapping categories, such as “hardly at all” and “a little,” should 
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be avoided. Simple questions are more effective, rather than difficult or branching questions 
(Khadka et al., 2012).  
 
Respondents’ perceptions of the influence of disease and treatment on their QoL were 
measured by means of the questionnaires or self-reported outcome instruments. A rating scale 
with different response options was used for each question in order to determine the 
participant’s status with regards to QoL issues. The response categories for the questionnaires 
were: yes/no/unsure. 
 
For the assessment of QoL, the researcher attempted to develop a simple questionnaire, due to 
the literacy level and the health status of the respondents, to prevent placing a high burden on 
them during completion of the questionnaire. The number of questions in each questionnaire 
was also limited to prevent overburdening of sick patients. From previous experience with the 
type of patients seen at the clinics, the researcher knew the patients had a low educational 
level and cancer patients are often very sick. For this reason a three-category global rating scale 
was used: yes/no/unsure. 
 
5.6 POPULATION AND SAMPLING 
 
The target population for this phase of the study was the same as for Phase 1: cancer patients 
receiving chemotherapy or radiotherapy, or both, at a public health care facility in South Africa. 
The accessible study population was cancer patients receiving treatment at the same academic 
hospital where the first phase of the study was conducted. 
 
Purposive and convenience sampling was used to select respondents. Purposive sampling is 
used where the researcher selects subjects who are typical of the population (LoBiondo-Wood 
and Haber, 2010) and convenience sampling implies the selection of respondents who are 
available at the location and time of the data gathering (Polit and Beck, 2008).  The researcher 
recruited respondents who received anti-cancer treatment for different types of cancer, 
represented different cultural groups, were of both male and female gender and lived in both 
rural and urban communities.  
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The inclusion criteria for the accessible population were: 18 years and older, receiving 
chemotherapy or radiotherapy, or both, for cancer at the oncology clinics at the Department of 
Radiation Oncology of the chosen hospital and willing to participate. Questionnaires 1 and 2 
were completed during February and March 2014.   
 
The sample size for the first two questionnaires was 91. Fifty respondents completed 
Questionnaire 1: What makes life hard for you? and 50 completed Questionnaire 2: What 
makes life good for you?, however, three questions in Questionnaire 1 and six in Questionnaire 
2 were only filled in partially and had to be discarded. The sample size for the first two 
questionnaires was small, as the instrument was still in the developmental phase. 
 
5.7 DATA GATHERING 
 
During data gathering the two questionnaires were pilot tested. Two fieldworkers, both 
Oncology Nursing Masters’ students, were enlisted to assist with the completion of the 
questionnaires. This occurred under the supervision of the researcher at the Department of 
Radiation Oncology at the academic hospital where the data gathering for Phase 1 of the study 
was conducted. Respondents were given information sheets about the study and written 
informed consent was obtained (Addendum F). Respondents who were illiterate were assisted 
with the completion of the questionnaires by the fieldworkers.  
 
5.8 VALIDATION OF THE INSTRUMENT BY MEANS OF THE RASCH MEASUREMENT MODEL 
 
The raw data from the questionnaires were captured onto Excel spread sheets.  Eight 
questionnaires from Questionnaire 1 and 2 were found to be incomplete and discarded. It was 
clear that the participants who completed only half of the questions did not understand the 
questions or were not really interested in completing the questionnaire.  The data were then 
exported into the RUMM 2030 program and subjected to the Rasch Measurement Model 
(RMM) for validation. In order to determine fit of a scale to the Rasch model, RUMM 2030, 
Winsteps, Facets, Quest or ConQuest software can be used (Hagquist et al., 2008). For the 
analysis of the questionnaires in this study, RUMM 2030 software was used.  
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The researchers selected the Rasch Measurement Model,  which is used for examining the 
psychometric properties and dimensionality of an assessment instrument (Pallant and Tennant, 
2007), as it had been used successfully in the development of measurement instruments in 
nursing research (Hagquist et al., 2008).  
 
By using the Rasch model for analysis, measurement issues can be detected. The model 
assumes that the probability of a participant endorsing an item is a logistic function of the 
relative difference between the item’s location (difficulty of the item) and the person’s location 
(ability of the person) (Zucca et al., 2012). The Rasch model can be described as a latent trait 
model, with overlapping characteristics of item response theory (IRT). The model is applied to 
an instrument to test unidimensionality, invariance, proper item categorisation and differential 
item functioning (DIF) (Tennant and Conaghan, 2007). 
 
In the RMM, item measures are presented as logits or scaled logits. Items which report item 
statistics must be arranged from most to least challenging. Item fit statistics are important to 
determine how well data fits the model (Pallant and Tennant, 2007). 
 
There are two derivations of the Rasch model, the Andrich Rating Scale Model and the Masters 
Partial Credit Model. If the distance between the thresholds or categories is the same across all 
the items, the Rating Scale Model is used, if the distances vary, the Partial Credit Model is used 
(Zucca et al., 2012). An equal distance between thresholds is expected, where the thresholds 
are “probabilistic midpoints between any two adjacent categories” (Tennant and Conaghan, 
2007) [p1359]. The category structure is tested to determine if the thresholds are ordered or 
disordered. In the case of disordered thresholds, categories may be collapsed where possible to 
make the data fit the model.  
 
For the QoL assessment instrument developed in this study the Masters Partial Credit Model 
was used, as the distances between the thresholds varied. When subjecting an instrument to 
the Rasch model, the researcher tests how well the observed responses conform to Rasch 
model expectations. It is important to note that the Rasch model requires the data to fit the 
model and not the other way round, as in classical test theory techniques where the researcher 
will explore different models until one is found that best fits the data (Andrich, 2004).  
   
 
54 
 
 
The following aspects need to be assessed in the Rasch model: model fit statistics, item and 
person fit statistics, response format, local dependency, targeting, item bias or differential item 
functioning (DIF), dimensionality (do the items of the proposed scale measure a single 
underlying construct), the person separation index (PSI) and reliability, which is assessed by 
means of Crohnbach’s alpha (Zucca et al., 2012). The requirements for each of these aspects 
are explained below. 
 
5.8.1 Determining fit of data to the Rasch model 
 
When testing how well data fit the RMM, three statistics need to be computed: item fit 
statistics; person fit statistics and item-trait interaction statistics or chi-square, which indicates 
invariance. If the chi-square value is less than 0.05, the item does not fit the model, because 
this points to a statistically significant difference between observed and expected values. An 
item-trait interaction chi-square can be obtained by adding the total chi-square values of all the 
items, which is an indication of the level of invariance of the items. If items and persons fit the 
model, the mean location score will be ± zero with a standard deviation of 1. In an analysis, 
individual person fit residuals of between +2.5 and -2.5 are regarded as an adequate fit to the 
model. Item fit deviations can be displayed graphically by means of an item characteristic curve 
(ICC) function (Pallant and Tennant, 2007).  
 
Another criteria  for evaluating a rating scale is threshold ordering, that is: thresholds must be 
ordered, categories must be even - not too close together, overlap, or be too far apart, and the 
range of response categories - a large range creates greater measurement coverage of the 
latent trait (Khadka et al., 2012). This is visually displayed by the category probability curves and 
the threshold map. 
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5.8.2 Item and person fit statistic 
 
Person fit has to be tested, as inconsistent response patterns of individuals have an effect on 
item fit. In case of serious misfit of individuals, the person’s response can be removed from the 
analysis to improve construct validity. This is seen as extreme persons in the Rasch Model. An 
example of an extreme person is where the responses for the entire questionnaire are the 
same. Inconsistent responses may be due to co-morbidities or cognitive impairment (Pallant 
and Tennant, 2007). 
In order to identify items and persons causing misfit, individual item and person fit residual 
values are computed; values >2.5 indicate misfit and <-2.5 indicate item redundancy (Pallant 
and Tennant, 2007). 
 
5.8.3 Response category functioning 
 
Item misfit is often the result of inconsistent use of response options by respondents, which is 
displayed as disordered thresholds. Disordered thresholds indicate that response categories are 
not used in a way that corresponds with the level of the trait being measured and that 
rescoring is necessary according to the item’s category probability curve.  Disordered 
thresholds often occur when there are too many response options or when the labeling of 
response options is potentially confusing, for example: sometimes, often and frequently. In this 
instance fit can be improved by means of the collapsing of categories which display disordered 
thresholds (Pallant and Tennant, 2007). When thresholds are arranged orderly, the rating scale 
functions well between response categories. If respondents do not use all the categories and 
cannot discriminate between categories, the rating scale is dysfunctional and the thresholds are 
disordered (Pallant and Tennant, 2007). 
 
5.8.4 Targeting 
 
Good measurement depends on good targeting, which implies the relative locations of persons 
and items. The number and difficulty levels of the items must cover the ability levels of the 
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persons with whom the instrument will be used. Incorrect targeting will result in incorrect 
estimates of item and person parameters and reversed thresholds. Mistargeting also increases 
the scoring of persons in the highest and lowest categories, which makes the estimation of 
person parameters difficult. Targeting is determined by comparing the mean location score for 
the persons with that of the value of zero; if the score is close to zero, the measure is well 
targeted (Tennant and Connaghan, 2007). In a well-targeted measure, which is not too easy or 
too hard, the mean location of persons is ± zero (Pallant and Tennant, 2007).  
 
5.8.5 Differential item functioning 
 
The validity of the scoring system and of individual item fit is tested and potential bias of items 
is assessed (Pallant and Tennant, 2007). When different groups of respondents respond 
differently to an item, differential item functioning (DIF) occurs. For example, if males respond 
differently to a question than females, the question might favour one gender. Invariance means 
there is no DIF across the group examined. DIF is also known as item bias (Pallant and Tennant, 
2007).  
 
When comparing groups from questionnaire data, items should not show DIF between these 
group variables, for instance, gender, age, race and level of education. Real DIF in items 
favouring one group can lead to artificial DIF in another group, which in turn can lead to 
incorrect identification of items as having real DIF. In order to detect artificial DIF, groups with 
real DIF must be identified. The item which shows the greatest DIF (the highest mean square) 
should be resolved by splitting it into two items. If the DIF was real, artificial DIF in other items 
is removed. The item with the greatest DIF can also be removed (Andrich and Hagquist, 2012).  
 
In RUMM2030, DIF is presented in graphs. The expected curve for an item is plotted with the 
group variable’s real performance alongside the curve. For example, if gender is the group 
variable, a separate curve for male and female is plotted alongside the expected curve. (Refer 
to Figures 6.2 – 6.6 in Chapter 6 for a clear understanding of the graphical presentation of DIF). 
 
A two-way analysis of variance (ANOVA) uses class intervals and compares it to the means of 
the group variables. Class intervals are constructed by dividing the sample into three groups of 
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ability (one group for low scores, one for in-between and one for high scores). Class intervals 
can be grouped into more classes depending on the sample size, but for the purpose of this 
study, class intervals were divided into three groups. ANOVA then reports on the interaction 
between the class intervals and group variables for examples gender groups. A p-value is 
calculated by RUMM2030 (based on the specific sample) as a criterion for significant difference 
between class intervals and the group variable. 
 
5.8.6 Local dependency 
 
Construct validity is further tested by means of testing response dependency. Where the 
response to one item determines the response to another item, the items are linked and 
breach of local independence occurs (Tennant and Connaghan, 2007). Local dependency 
between items is examined by means of the residual correlation matrix; if the correlation 
between pairs of items exceeds 0.3, it indicates dependency (Zucca et al., 2012). 
 
5.8.7 Dimensionality 
 
Unidimensionality must be demonstrated when validating an instrument. This implies the 
instrument is measuring the construct it claims to measure. For example, if the instrument 
claims to measure QoL, it should only measure this construct and no other related constructs. 
For a scale to conform to the Rasch model’s requirement for unidimensionality, items should be 
independent. When there are subsets of items intended to include different aspects of a 
construct, it leads to multidimensionality (Hagquist et al., 2008).  
 
The Rasch model provides a template for the development and testing of a unidimensional 
scale and for the conversion of ordinal data to a linear scale if the data fit the model. 
Unidimensionality is achieved if there is no meaningful pattern in the residuals and local 
independence between items is evident. Under these circumstances, the scores of items or 
questions in an instrument may be added up or summated for one total score per person 
(Tennant and Connaghan, 2007). 
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5.8.8 Person Separation Index and reliability 
An instrument needs to be sensitive enough to differentiate between high and low levels in 
persons. Values higher than 2 in the person separation index (PSI), points to the sensitivity of 
the instrument. A Crohnbach’s alpha larger than 0.8 indicates the instrument will consistently 
be sensitive (Mallinson, 2007). For an instrument to be reliable, the minimum Crohnbach’s 
alpha score must be 0.7 (Adnane et al., 2016).  
 
5.8.9 Resolutions in the Rasch model 
 
During examination of a scale by means of the Rasch model, weakness in the functioning of the 
instrument is discovered, but can be resolved. If thresholds are disordered, categories can be 
collapsed on the response format to reduce confusion of the points on the scale.  Furthermore, 
the scale can be adjusted by means of new items or by removing items which do not fit. Items 
which do not fit can be removed one by one until the problem is resolved. Items should rather 
be resolved than removed, as removal of too many items may decrease the reliability of the 
measure (Andrich and Hacquist, 2012). When local dependency is detected, it may be resolved 
by sub-testing of items. This is done by grouping items with residual correlations above 0.2 into 
one subtest. Theoretical support and clinical reasoning should accompany decisions when 
grouping items into subtests. 
 
When all the above aspects conform to the Rasch model expectations the instrument’s raw 
data are converted to linear scales, which can be used for comparing differences in patient 
function over time during cancer treatment, differences between patients suffering from 
different cancers, different genders and patients treated in public and private hospitals.  
 
The above analyses were applied to Questionnaire 1 and 2. The results of the analyses are 
presented in Chapter 6. The data of both questionnaires did not fit the requirements of the 
Rasch model and many resolutions had to be made, the major resolution being to combine 
Questionnaire 1 and 2 and create a third questionnaire. During this process, questions which 
proved to be unclear and were a misfit were removed. It also appeared there were too many 
questions in the two questionnaires, which in turn was too tiring for the respondents. Some 
questions were not removed but rephrased. Questionnaire 3: What makes your life good and 
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hard (Addendum I) contained 67 questions. The same process of data analysis was followed 
with the third questionnaire as with the first two questionnaires. New data were gathered at 
the same oncology clinics during June to August 2014, with the assistance of the two Oncology 
Nursing Masters’ students. The data from Questionnaire 3 were again captured on an Excel 
spread sheet and transferred to the RUMM 2030 program before being submitted to the Rasch 
Measurement model for validation. The results of the validation process are discussed in 
Chapter 6. 
 
5.9 ETHICAL PRINCIPLES 
 
The same ethical principles, as described in Phase 1, applied to Phase 2 of the study. 
Respondents took part in the study voluntarily. Before completing the questionnaire, an 
information leaflet was handed to each respondent and the purpose of the study and what was 
expected from the respondent was explained. Informed consent was obtained (Addendum F).  
 
5.10 VALIDITY AND RELIABILITY 
 
To ensure validity and reliability of the research, the researcher should ensure rigour and 
control throughout the research process. Rigour can be described as striving for excellence in 
the research process, by means of precision and control. Each step in the research process 
should be carried out with meticulous attention to detail and should be linked together in a 
logical way. The research process should be described accurately and in detail (Burns and 
Grove, 2009). In this study the researchers described each step in the research process in detail. 
 
The researcher needs to control extraneous variables as much as possible to be able to identify 
relationships between study variables accurately. Ways to control extraneous variables are: 
random sampling of the study population, inclusion criteria and choosing the setting to control 
variables, such as temperature and noise levels (Burns and Grove, 2009). The sampling 
procedure and inclusion criteria must be described in detail, which was adhered to in this study. 
The characteristics of the respondents must be described, as it could influence the findings of 
the study.  
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Data gathering should be done in a structured way, with the procedure described in detail  
(McCarthy and O'Sullivan, 2008).  Data gathering took place in the Department of Radiation 
Oncology of the hospital where the study took place and private rooms were available to 
ensure privacy, comfort and confidentiality. Data gathering must be controlled by means of a 
good quality measurement instrument. The data analysis from the first phase of the study was 
used for compiling the questionnaires, which were used for data gathering. 
 
Research outcomes can be influenced by respondents’ knowledge of the study, for example the 
Hawthorne effect, which implies that being part of a study can have an influence on 
respondents’ behaviour (Burns and Grove, 2009). During data gathering, respondents were 
informed about the study and that all data gathered would be anonymous, as questionnaires 
did not contain the respondents’ names, only numbers. Respondents took part in the study 
voluntarily and were assured there would be no consequences if they refused to take part.  
 
In quantitative research the researcher should explain the rationale for conducting the study, 
based on the identification of a gap in the knowledge base according to the literature. Sample 
sizes are usually larger than in qualitative research (McCarthy and O'Sullivan, 2008). In this 
study the sample sizes for Questionnaires 1 and 2 were 47 and 44 respectively and for 
Questionnaire 3, 195. The sample size was not very large, due to the fact that the instrument 
was still in the developmental stage. 
 
In addition, the data analysis process should be described comprehensively, with graphs and 
tables explained and labeled clearly. Interpretation of the results must be explained and the 
researchers must indicate whether the aims of the study were met, as well as what the 
implications of the research are for clinical practice (McCarthy and O'Sullivan, 2008). The data 
analysis process, which entailed validation of the questionnaires by means of the Rasch 
Measurement Model, will be discussed in detail in Chapter 6. 
 
5.11 SUMMARY 
 
Chapter 5 presented the Methods for Phase 2 of the study in terms of the purpose and aim, the 
research design and research process. The development of the questionnaires was described, 
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followed by the data gathering- and validation of the instrument. The Rasch Measurement 
Model was discussed, as well as the ethical principles which underpinned the study and 
measures taken to ensure validity and reliability. The results of the validation of the 
instruments will be discussed in Chapter 6.   
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CHAPTER 6 
 
RESULTS AND DISCUSSION OF PHASE 2 
 
6.1 INTRODUCTION 
 
Chapter 5 discussed the Methods of Phase 2. In Chapter 6, the results of Phase 2 will be 
discussed. Psychometric testing was done to validate each of the three questionnaires which 
were developed for a QoL instrument for cancer patients.  
 
The demographic data are presented and results of the validation process for each 
questionnaire are described. The chapter ends with a discussion of the results of the 
psychometric testing. 
 
6.2 RESULTS OF RASCH ANALYSIS 
 
The QoL instrument consisted of two questionnaires, namely Questionnaire 1: What makes life 
hard for you? and Questionnaire 2: What makes life good for you?  Each questionnaire 
consisted of questions which the respondent had to endorse by choosing between three 
response options: Yes, No or Unsure. In the reporting of the results, the term item is used for 
the questions in the QoL instrument.  
 
The demographic data of the respondents who completed Questionnaires 1 and 2 are 
summarised in Table 6.1  
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Table 6.1: Demographic data of respondents who completed Questionnaires 1 and 2 
 
Variable 
Questionnaire 1 
(n=47) 
Questionnaire 2 
(n=44) 
Age    
   19-29 6 5 
   30-39 6 6 
   40-49 6 5 
   50-59 14 13 
   60-69 10 11 
   70-79 4 4 
   80-89 1 0 
Gender   
   Male 21 20 
   Female 26 24 
Cultural group   
   Coloured 5 6 
   Asian 3 4 
   Black African 27 24 
   White 12 10 
Highest level of education   
   Grade 10-12 26 25 
   None 3 4 
   Grade 1-9 10 9 
   Tertiary 8 6 
Cancer group   
   Head and neck 4 3 
   Gynaecological 8 8 
   Haematological 13 12 
   Breast 9 9 
   Lung and oesophageal 6 5 
   Prostate 1 2 
   Colon and kidney 6 5 
 
The majority of respondents who completed the first two questionnaires was between 50 and 
69 years old, had a greater number of females than males and consisted mainly of the Black 
African cultural group. The educational level of the majority of respondents was grade 10 to 12 
level; three respondents who completed Questionnaire 1 and four who completed 
Questionnaire 2 had not attended school at all. Twenty seven per cent of respondents who 
completed Questionnaire 1 and 29.5% who completed Questionnaire 2 did not have any high 
school education. The majority of respondents suffered from haematological cancers, followed 
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by gynaecological and breast cancer. When combining gynaecological and breast cancer, 
female cancer was the most common.  
 
The analyses of the different questionnaires will be discussed separately. 
 
6.2.1 Analysis of Questionnaire 1: What makes life hard for you? 
 
6.2.1.1 Fit of data to the Rasch Model 
 
The fit statistics of the Rasch model for Questionnaire 1: What makes life hard for you?  are 
summarised in Table 6.2. This includes the chi-square statistic, the mean location of items, the 
standard deviation, item fit, the person separation index (PSI) and the threshold ordering. The 
criteria for each of these fit statistics are provided in brackets.  
 
Table 6.2: Fit statistics of Questionnaire 1: What makes life hard for you? 
 
Run 
Number 
 
Chi square 
(˃0.05) 
Person 
mean 
location 
(= 0) 
Person 
standard 
deviation 
(=1) 
Item fit 
(± 2.5) 
PSI 
(˃0.85) 
Threshold 
ordering 
1 
0.098 -1.736 0.790 
Item 1 misfit 
(3.019) 
0.907 
Item 24 
disordered 
2 
Item 1 deleted 0.141 -1.741 0.814 
Item 28 
misfit 
(2.534) 
0.911 
Item 24 
disordered 
3 
Clinical 
evaluation to 
reduce 
number of 
questions 
0.502 -1.788 0.824 All items fit 0.886 
Item 24 
disordered 
4 
Item 24 
deleted and 
Category 3 
collapsed 
0.021 -0.003 1.099 All items fit 0.891 Ordered 
5 
Six Subtests  
0.156 -0.246 1.022 
All subtests 
fit 
0.85 N/a 
6 
Five Subtests 
0.673 -0.226 0.947 
All subtests 
fit 
0.839 N/a 
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Several rounds of analyses were done to conform to the requirements of the Rasch model. The 
first round (see Table 6.2 Run 1) indicated a fitting chi-square statistic with a value of 0.098.  
The mean location and standard deviation of items and persons are reported in Table 6.2 
columns 3 and 4. Item 1 (question 1) was highlighted as over-fitting (3.019). The PSI showed 
good discrimination between groups and good internal consistency of the questionnaire. Item 
24 (question 24) was disordered. The other 66 items were all ordered. A second analysis was 
done (run 2) to resolve the misfit of item 1 and the disordering thresholds of item 24.  Item 1 
was deleted but item 24 was still disordered and item 28 showed over-fit (2.534).  
 
Due to the fact the respondents were cancer patients, the researcher wanted to reduce the 
number of questions to prevent over-burdening when completing the questionnaire. Despite 
the relatively sufficient fitting statistics for Questionnaire 1, the questions were evaluated from 
a clinical perspective and 17 items, which were unclear or duplicated, were deleted in the third   
round of analysis (run 3). After the reduction of the number of questions, item 24 was still 
disordered, but all remaining items fit between ±2.5.   
 
When looking at the completed questionnaires, the researcher observed a great deal of doubt 
in the respondents between response options and realised the format of the questions was not 
the same, for example, when determining what made life hard, one question asked: Not being 
able to work: yes/no/unsure and another question: Being too tired to carry out your normal 
activities of daily living: yes/no/unsure. The third category (unsure) seemed to have created the 
doubt and for this reason the response format was changed for all the items. The response 
category of unsure was collapsed throughout, to create a dichotomous format of yes/no for all 
the questions (run 4). The mean location improved markedly from -1.736 in the first analysis to 
-0.003 in the fourth round of analysis. The standard deviation also improved from 0.79 to 1.099. 
All items were ordered with a dichotomous response format. The chi-square statistic however 
was not fitting at 0.021.  
 
A fifth round of analysis was done by creating subtests according to the domains of QoL to 
improve the chi-square statistics. Six subtests were created namely Physical, Financial, 
Emotional, Existential, Social and Spiritual. After Run 5 of the analysis the data fitted the model. 
Subtest Existential consisted of only two questions and Spiritual only one question. It was 
   
 
66 
 
decided to combine Existential and Spiritual into one subtest as, theoretically, these two 
concepts are strongly associated. This combination proved to be successful as the final and 
sixth round of analysis resulted in an even better fit (χ2 = 0.673) with the Rasch Model 
requirements. A mean location of -0.226 and standard deviation of 0.947 were achieved.  
Throughout the six rounds of analyses, person mean location and person standard deviation, as 
well as the PSI, were within normal limits.  
 
6.2.1.2 Targeting difficulty of items to ability levels of persons 
 
Targeting showed some categories with no responses (Figure 6.1). Persons had a mean of -
0.226 and standard deviation of 0.947, which showed the items were well targeted for the 
sample. 
 
 
Figure 6.1:  Person-item threshold distribution of Questionnaire 1 
 
6.2.1.3 Differential item functioning 
 
Differential item functioning (DIF) was only done for gender as the other person factors, such as 
age group, highest level of education, culture and cancer group, had too few respondents per 
category. The two-way ANOVA statistic in RUMM2030 was done for each of the five subtests. 
This was done to see if there was a significant difference between the mean of the class 
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intervals and the mean of the gender variable. The p-value criterion was set at 0.0033; 
iterations below 0.0033 would show DIF for gender in that specific subtest.  Table 6.3 shows the 
results of the two-way ANOVA. It is interesting to note that there was no DIF for gender 
according to the ANOVA results, however, the graphical presentations of DIF (Fig 6.2 to 6.6) 
show that the curves for males and females do not follow the expected curve exactly.   
 
Table 6.3: DIF summary for five subtests with criterion at P<0.00333 
 
 Class interval  Gender  Class interval by gender 
Subtest MS F DF Prob  MS F DF Prob  MS F DF Prob 
Physical 0.096 0.12856 2 0.879 
 
0.096 0.128 1 0.722 
 
0.390 0.520 2 0.598 
Financial 0.482 0.61067 2 0.548 
 
0.390 0.494 1 0.486 
 
1.122 1.421 2 0.253 
Emotional 0.064 0.05948 2 0.942 
 
1.052 0.967 1 0.331 
 
0.558 0.512 2 0.602 
Existential & Spiritual 1.476 2.24412 2 0.119 
 
3.638 5.530 1 0.023 
 
-0.056 -0.08 2 0.999 
Social 1.290 1.67129 2 0.200 
 
0.167 0.216 1 0.643 
 
2.019 2.615 2 0.085 
 
This discrepancy between ANOVA results and graphical presentation could be explained by the 
small sample size of 47 and then split into male (n=21) and female (n=26).  One would have 
expected DIF due to the fact that only women had breast and gynaecological cancers, which 
represented the largest group, while only men had prostate cancer, which represented the 
smallest group of participants. The results for DIF for this study are thus inconclusive at this 
stage. 
 
 
Figure 6.2:  Physical factors DIF for gender 
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Figure 6.3:  Financial factors DIF for gender 
 
 
Figure 6.4:  Emotional factors DIF for gender 
 
 
Figure 6.5:  Existential- and spiritual factors DIF for gender 
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Figure 6.6:  Social factors DIF for gender 
 
6.2.1.4 Local dependency 
 
Local independence between the five subtests was achieved. The implication was that subtests 
do not overlap significantly or provide cues for another subtest. Table 6.3 shows the residual 
correlations between subtests were all well below the criteria of 0.3 correlation.  
 
The interpretation in terms of validity of this questionnaire was that each subtest contributes 
something towards quality of life in a person with cancer.  
 
Table 6.4: Residual correlations of the 5 subtests of Questionnaire 1 
 
 
6.2.1.5 Unidimensionality 
 
Unidimensionality was achieved. The t-test showed an insignificant difference between groups 
and only 4.65% fell outside the recommended criteria of 5%. This means the individual scores 
Subtests Physical Financial Emotional 
Existential and 
spiritual 
Social 
Physical 1     
Financial -0.242 1    
Emotional -0.853 -0.127 1   
Existential and 
spiritual 
-0.369 0.144 0.034 1  
Social -0.172 -0.187 -0.074 -0.016 1 
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of each subtest may be summed to get a total that will indicate the degree of QoL in a cancer 
patient.  
 
6.2.1.6 Summary of results of Questionnaire 1 
 
The results of the analysis when using the Rasch model generally fitted the requirements of the 
model after certain resolutions were done. These resolutions include deleting items, collapsing 
the response options to a dichotomous scale of yes/no and sub-testing the items. Differential 
Item Functioning was the one criterion that was inconclusive. 
 
6.2.2 Analysis of Questionnaire 2: What makes life good for you? 
 
The results of the analysis of Questionnaire 2 - What makes life good for you? - are summarised 
in Table 6.5.  
 
Table 6.5: Analysis of Questionnaire 2: What makes life good for you? 
 
Run 
number 
Chi square 
 
(˃0.05) 
Mean 
location 
(= 0) 
Standard 
deviation 
(=1) 
Item fit 
 
(± 2.5) 
PSI 
 
(˃0.85) 
Threshold 
ordering 
1 
Collapsed 
category 3 
0.029 -2.217 1.241 All items fit 0.778 Ordered 
2 
Deleted 12 
items 
0.086 -2.351 1.249 All items fit 0.705 Ordered 
3 
Subtests (6) 
0.099 -2.137 0.999 All items fit 0.183 Ordered 
 
During the first round (run 1) of analysis of Questionnaire 2, response category 3 was collapsed 
due to the fact that in the analysis of Questionnaire1 it showed better fit with the Rasch model 
when there were only two categories.  It was apparent that the category unsure created 
confusion. The response options thus changed from a three point (polytomous) to a 
dichotomous scale. 
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In the second round (run 2) of analysis the questions were clinically evaluated and those that 
were unclear, similar or duplicated were removed to reduce the number of questions. Twelve 
items were removed in total. Sub-testing was done by dividing the remaining questions into six 
groups according to the domains of QoL, similar to those in Questionnaire 1. 
 
The data did not fit the Rasch model expectations and even with attempts to resolve the issues, 
the chi-square was constantly below 0.05 and the PSI indicated the instrument did not 
distinguish between high and low QoL (Table 6.5). It also reflected that the data were of poor 
quality. It was decided not to go ahead with any resolutions, but rather attempt to combine the 
two questionnaires into one, resulting in Questionnaire 3. 
 
As discussed in Chapter 5 (5.8), Questionnaire 3 (Addendum I) was developed by combining the 
remaining questions of Questionnaire 1 and 2 and by rephrasing the questions which were 
problematic. The questionnaire consisted of 67 questions.  
 
The accessible population consisted of patients who received anti-cancer treatment at the 
clinics in the Department of Radiation Oncology of the academic hospital where the study was 
conducted. Like in the first two questionnaires, purposive and convenience sampling was 
applied and respondents who were present in the clinics during data gathering were recruited 
and included patients who were receiving treatment for different cancers, were of both 
genders and different cultural groups. 
 
During data gathering the questionnaire was pilot tested with the assistance of the Oncology 
Nursing Master’s students who assisted with the first two questionnaires. Inclusion criteria 
were the same as for the first two questionnaires: respondents had to be 18 years or older, 
receiving treatment for cancer at the clinics where data gathering took place and willing to take 
part in the research. 
 
The sample size for Questionnaire 3 was initially 199, however, four questionnaires were only 
completed partially and had to be rejected. Two groups of respondents completed the 
questionnaire: 100 respondents were receiving active treatment for cancer and 95 respondents 
were seen for follow up at six months or twelve months after completion of treatment. The 
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sample size was bigger than with the first two questionnaires, as the researcher wanted to 
determine what the effect of cancer treatment was on QoL by comparing the findings of 
respondents on active treatment with the findings of those seen for follow up after treatment.  
 
6.2.3 Analysis of Questionnaire 3: What makes your life good or hard? 
 
The demographic data of the respondents who completed Questionnaire 3 were summarised in 
Table 6.6. 
 
Table 6.6: Demographic data of respondents who completed Questionnaire 3  
 
Variable Questionnaire 3 (n=195) 
Age   
   19-29 9 
   30-39 47 
   40-49 51 
   50-59 43 
   60-69 29 
   70-79 13 
   80-89 3 
Gender  
   Male 48 
   Female 147 
Cultural group  
   Coloured 19 
   Asian 6 
   Black African 147 
   White 23 
Highest level of education  
   Grade 10-12 89 
   None 7 
   Grade 1-9 55 
   Tertiary 44 
Cancer group  
   Head and neck 12 
   Gynaecological 88 
   Haematological 25 
   Breast 34 
   Lung and esophageal 11 
   Prostate 9 
   Colon and kidney 9 
   Bone and skin 7 
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In this sample the average age was lower than the previous sample, with the majority of 
respondents being between 30 and 70 years old and females comprised 75.3% of the sample. 
As in the previous sample, Black African patients were also in the majority, numbering 147 in 
total (75.3%). Gynecological cancers comprised the biggest group of respondents, followed by 
breast cancer, which implies that female cancers formed the largest section of the sample. The 
average educational level was higher in this sample, with 44 respondents (22.6%) tertiary 
qualified, compared to the sample of the first two questionnaires, which comprised 17% and 
13.6% who had a tertiary qualification. The greatest majority of respondents (73.8%) had 
attended school and only seven (3.6%) had not attended school at all. A total of 62 respondents 
(31.8%) did not have a high school education, which confirmed the suspicion of the researcher 
that the educational level of many of the respondents would be low.  
 
After completion of the questionnaires, the data were again captured on an Excel spread sheet 
and transferred to the RUMM 2030 program for validation by means of the Rasch model. The 
results of the analysis of Questionnaire 3 are summarised in Table 6.7. The data sets of the first 
100 respondents receiving active treatment and the 95 respondents who were seen for follow 
up were combined due to the fact that a comparison between QoL during treatment and follow 
up was not intended at this stage, but served to increase the sample size to improve the data 
quality of the validation process.  
 
While capturing the data on the Excel spread sheet, four questionnaires were found to be 
incomplete and discarded. The total number of questionnaires for analysis was 195. The sample 
size was greater than for the first two questionnaires as the researcher expected the third 
questionnaire to show better results during the validation process, but it was not too big as the 
questionnaire was still in the developmental phase.  
 
A dichotomous scale was used to make the questionnaire easy to complete for patients 
suffering from cancer.  During the first round of analysis all thresholds were ordered. Items 3, 
23, 27, 28, 30, 37 and 49 showed misfit. The questions were evaluated clinically and reasons 
were sought why the questions did not fit. The Chi Square was 0.000. 
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In round 2, the misfit items 3, 23, 27, 28, 30, 37 and 49 were deleted. All items fit, but the chi-
square values did not change significantly. 
Table 6.7: Analysis of Questionnaire 3: What makes life good or hard? 
 
Run 
number 
Chi 
square 
(˃0.05) 
Mean 
location 
(= 0) 
Standard 
deviation 
(=1) 
Item fit 
 
(± 2.5) 
PSI 
 
(˃0.85) 
Threshold 
ordering 
1 0.000 -1.409 1.266 Item 3 (-2.679) 
Item 23 (3.479) 
Item27 (-3.332) 
Item 28 (-2.576) 
Item 30 (-2.529) 
Item 37 (3.977) 
Item49 (-2.717) 
0.910 All ordered 
2 
Deleted 
Items 3, 
23, 27, 28, 
30, 37, 49 
0.000 -1.494 1.261 All items fit 0.892 Ordered 
3 
Deleted 
extreme 
persons 
66, 98, 
121 
0.000 -1.437 1.182 All items fit 0.891 Ordered 
4 
Subtests 
Individual 
Item Fit  
0.000 -1.021 1.038 Subtests misfit 0.856 Ordered 
5 
Subtests 
clinical 
0.000054 -1.154 0.6738 Subtests fit 0.788 Ordered 
 
During round 3, extreme persons 66, 98 and 121 were deleted. All items fit, but again the 
reported chi-square values did not change significantly. 
 
In round 4, subtests were created according to individual item fit, but the subtests did not fit. 
 
Further resolutions were sought and during round 5, subtests were created clinically according 
to the domains of QoL identified in Phase 1. After this attempt the subtests fitted the model, 
except for the chi-square (0.000054) that still indicated a misfit. The PSI dropped to 0.788, 
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which indicated that the data of this sample were less reliable. The mean item location and 
standard deviation were not close to the suggested criteria of 0.00 and 1.0 respectively. 
After several attempts to resolve the misfit issues, a solution could not be found. It seemed that 
the combination of negative and positive factors in one questionnaire could have led to 
misinterpretation of the questions, thus making the questions in Questionnaire 3 difficult to 
endorse for the participants in this sample. 
 
6.3 DISCUSSION 
 
The uniqueness and contribution of this study is that it developed a QoL instrument for cancer 
patients in South Africa using public health care for cancer treatment. The assessment 
instrument which was developed and validated will in future be called the South African Quality 
of Life Instrument for Cancer patients (SAQOLI-Ca). In addition, this was a patient-directed 
instrument, as the researcher first investigated what QoL means to these patients where after 
the instrument was developed. As discussed in Chapter 1, the meaning of QoL differs from 
person to person, as individuals place subjective priorities on their own value and what 
constitutes QoL to them (Chippendale, 2001). Experience of QoL depends on the perspective of 
the individual and not the perspective of the health care provider.  Bennett and Closs (2008) 
describe QoL as a broad, complex and highly individual concept, which involves the total 
assessment of all aspects of daily life. Mitera, Zeiadin, Sahgal and Finkelstein et al. (2011) agree 
that QoL assessment should be done from the patient’s perspective and not as perceived by 
health care providers.      
 
When reflecting on possible reasons for the two questionnaires (Questionnaires 2 and 3) which 
showed poor fit to the Rasch model, the researcher realised that Questionnaire 2 and 3 did not 
test what she intended to test. The aim with developing the QoL instrument was to identify and 
manage problems which have a negative influence on QoL. Questionnaire 2 and 3 determined 
what had a positive influence on QoL, which was not the intention of the researcher.   
 
Even though Questionnaire 1: What makes life hard for you? met the expectations of the Rasch 
model, the structure of the questions could be changed to make the questionnaire easier for 
persons with a low educational level and cancer patients to complete, as was attempted in 
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Questionnaire 3. An example is: Question 3: Not being able to work: yes/no in Questionnaire 1 
was changed to: Life is hard because I am not able to work: yes/no in Questionnaire 3. The 
researcher hoped that the questions would be clear and easy to answer, but, when looking at 
the answers and during the validation process realised that the questions could be simpler. The 
format of the questions was changed in Questionnaire 3 and appeared to be more 
understandable to the respondents.  
 
The combination of negative and positive factors in one questionnaire, like in Questionnaire 3, 
seemed to have led to misinterpretation of the questions. Questions about factors which make 
life good and hard were mixed. For instance, Question 6 asked whether Life is hard because I 
cannot eat, whilst Question 23 asked whether Life is good because my symptoms are controlled 
well by the medication. A possibility is that respondents, who were experiencing distressing 
symptoms such as pain or adverse social- or financial factors such as a lack of income, could 
have answered questions about good QoL differently than when they did not have such 
problems. It is quite possible that respondents with a low educational level or language 
difficulty could have misunderstood the questions and given different answers than intended. 
Twenty-eight percent of respondents who completed Questionnaire 1, 30% of respondents 
who completed Questionnaire 2 and 31% of respondents who completed Questionnaire 3 had 
less than a secondary school education. 
 
During validation of the three questionnaires, creating subtests improved the fit of the data to 
the Rasch model. When further validation of the QoL instrument is done in future, the 
researcher proposes that the questions in the questionnaire be grouped according to domains 
of QoL, like in the WHOQOL-BREF, the FACT-G and the Ferrans conceptual model for QoL 
(Ferrans, 2011). 
 
Even though Questionnaire 3 did not test what was intended, the researcher was interested to 
see what the difference in  respondents’ evaluation of QoL issues was during treatment and six 
or twelve months after treatment. When comparing QoL of respondents who were receiving 
active treatment with the QoL of respondents during follow up visits six or twelve months after 
treatment (Table 6.8), it was clear that the QoL of the respondents on treatment was much 
worse than during follow up, which suggested that symptoms might not have been assessed 
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and managed effectively. Therefore, it might have been quite possible that the QoL of the 
patients on treatment could have been better if QoL had been assessed during the patient’s  
 
Table 6.8: Comparison of problems identified by the treatment- and follow up group 
Domain Treatment group % Follow up group % 
Physical 48.2 32.6 
Financial 54.5 47.7 
Psychosocial 26.5 18.4 
Spiritual 13.2 8.4 
Existential 16.3 14.8 
Emotional 31.7 27.0 
 
 
first visit to the oncology unit and during subsequent visits, in order to identify and address 
problems timeously. This could have led to early identification of the patients’ problems and 
also guided the manner in which these problems were addressed.  
 
When the researcher reflected on the sample size for Phase 2 of the study she realised it was 
relatively small when compared with other studies which developed new instruments. For 
instance, the study on meaning on life conducted in South Africa, Australia and New Zealand 
(Schutte et al., 2016), which used a sample of 601 and a study on nutrition literacy (Guttersrud 
et al., 2013), which used a sample of 473. However, none of the samples included sick people; 
the sample for the meaning of life study consisted of members of the general public and the 
study on nutrition literacy used respondents who were nursing students. The smaller sample 
sizes of 47, 44 and 195 for the three questionnaires respectively, were used due to the fact that 
the instrument was still in the developmental phase. Also, respondents were cancer patients 
known to experience side-effects related to their disease and treatment, therefore, the 
researcher did not want to burden too many cancer patients with completion of the 
questionnaires which still contained too many questions.  
 
However, the sample size of 195 for Questionnaire 3 compares positively to other studies 
involving cancer patients, such as a study for the validation of the EuroQol Five-dimension 
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(EQ5D) instrument for an Indian population (Tripathy et al., 2015), which used a sample of 150 
cancer patients. Other studies for the validation of the University of Washington Quality of Life 
Questionnaire for patients with head and neck cancer (Adnane et al., 2016), and for the 
association of coping styles with QoL in cancer patients (Shakeri et al., 2015), used a sample of 
104 and 150 cancer patients respectively.  
 
It was clear that of the three questionnaires Questionnaire 1: What makes life hard for you? 
(Addendum G) fitted the Rasch model best. Questionnaire 2: What makes life good for you? 
(Addendum H) and Questionnaire 3: What makes your life good or hard? (Addendum I) did not 
fit the model. In Questionnaire 2 the chi-square was constantly below 0.05 and the PSI 
indicated that the instrument did not distinguish between high and low QoL (Table 6.4). In 
Questionnaire 3 the chi-square (0.000054) indicated a misfit. The PSI of 0.788 indicated that the 
data of the sample were less reliable. The mean item location and standard deviation were not 
close to the suggested criteria of 0.00 and 1.0 respectively. 
The suggestion of the researcher is that Questionnaire 1: What makes life hard for you? 
(Addendum G) be tested in the clinical field to determine the effectiveness to assess QoL of 
cancer patients in South Africa who access public health care for cancer treatment.  
 
6.4 SUMMARY 
 
In Chapter 6 the findings of Phase 2 of the study were discussed with regards to the 
development and validation of three QoL assessment questionnaires. After the validation of the 
questionnaires, Questionnaire 1: What makes life hard? conformed to the expectations of the 
Rasch Measurement Model and the researchers propose that the instrument be tested for 
applicability for the assessment of QoL of South African cancer patients. The demographic data 
of the respondents who completed the three questionnaires were presented before presenting 
the results of the Rasch analysis of the different questionnaires. Thereafter the researchers 
reflected on the findings of Phase 2. Chapter 7 will present the justification, limitations and 
recommendations for further research.  
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CHAPTER 7 
 
JUSTIFICATION, LIMITATIONS AND RECOMMENDATIONS 
 
7.1 INTRODUCTION 
 
The focus of Chapter 7 is the justification of the study, in terms of the purpose and aims, the 
research process, limitations and recommendations for further research. Through the 
exploration of QoL from the perspective of cancer patients in South Africa, the domains of QoL 
applicable to them were identified. A new instrument was developed for the assessment of QoL 
of cancer patients in South Africa. 
 
7.2 JUSTIFICATION OF THE STUDY  
 
The study focused on the quality of life of cancer patients in South Africa who access public 
health care for treatment and aimed to add to the body of knowledge of cancer care, in an 
attempt to develop and validate a patient-directed QoL instrument.  
 
A mixed methods study was conducted. Qualitative interviews were conducted in order to 
identify domains of QoL which are applicable to South African cancer patients who access 
public health care for treatment. After transcribing the interviews and analysing the data, the 
following domains were identified as being applicable: physical-, financial-, social-, spiritual- 
emotional- and existential. When comparing these domains with the domains included in QoL 
instruments which are commonly used for cancer patients, such as the EORTC QLQ-C30, the 
WHOQLQ-BREF and the FACT-G, the domains were not the same, especially with regards to the 
financial-, spiritual- and existential domains. 
 
 It was clear that most of the study participants had to cope with financial difficulties as well as 
the effects of cancer and treatment. These findings can be compared to a study in the United 
States of America, which indicated that Latino-, Chinese- and African American cancer patients 
with a low income also suffered from severe financial strain while having to cope with a cancer 
diagnosis and that patients’ needs with regards to an income, employment and transport are 
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often not met, just like in this study (Gany et al., 2015). The authors confirm that health care 
providers need to identify financial problems of cancer patients and provide support by 
referring patients to social services in order to improve QoL. The findings are also confirmed by 
a study on coping styles of cancer patients, which confirms the negative influence of a low 
income on QoL (Shakeri et al., 2015). 
 
The quantitative part of the study developed and validated a new QoL assessment instrument. 
After analysing the data gathered in Phase 1 of the study, the categories were operationalised 
into questions and two questionnaires were compiled. The researcher divided the questions 
into two questionnaires to limit the number of questions and not place a too high burden on 
cancer patients when completing the questionnaires.  
 
During the validation of the first two questionnaires by means of the Rasch model, some of the 
questions were problematic. When looking at the questions, the researchers found that some 
of the questions were asked in a positive way, such as: Being too tired to carry out your normal 
activities of daily living and other questions were asked in a negative way, such as: Not being 
able to enjoy life. The questions could have been confusing to respondents who had a low 
literacy level. Twenty-seven percent of the respondents who completed Questionnaire 1 and 
29.5% of the sample who completed Questionnaire 2 did not have a secondary school 
education. The three response options: yes/no/unsure also appeared to be confusing for some 
of the respondents. After removing response option unsure, the questionnaire fitted the Rasch 
model better. 
 
After removing categories which were problematic or duplicated, subtests were created 
according to domains of QoL. Questionnaire 1: What makes life hard for you? conformed to 
Rasch model expectations.  
 
For Questionnaire 3 the format of the questions was changed and duplicated questions were 
removed. The researcher expected the questionnaire to work well and tested it with a larger 
sample of 195 respondents. This questionnaire did not conform to Rasch model expectations. 
When reflecting on possible reasons why the questionnaire did not fit the model, the 
researcher realised that the questionnaire did not only test what was intended, namely which 
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factors had a negative influence on QoL, in order to identify problems timeously. Clinical 
evaluation of the questions was needed to understand why certain questions were 
problematic. 
 
Questionnaire 1: What makes life hard for you? fitted the Rasch model best and was accepted 
for testing in the clinical field. After testing the instrument further and validating it for other 
populations in South Africa, the questionnaire will be known as the South African Quality of Life 
Instrument for Cancer Patients (SAQOLI-Ca).  
 
The study met all the objectives of the study as described in Chapter 1. The aims of the study as 
described in Chapter 1 were to explore QoL from the perspective of cancer patients in South 
Africa who access public health services for treatment and to develop and validate a patient-
directed QoL assessment instrument. Chapter 2 presented a literature review and Chapter 3 
the methods of Phase 1 of the study. Chapter 4 presented the findings of Phase 1 of the study 
and discussed QoL from the perspective of cancer patients in South Africa who accessed public 
health care for cancer treatment. 
 
Chapter 5 presented the methods of the quantitative phase of the study, Phase 2, including the 
development of the questionnaires and the Rasch Measurement Model, which was used for 
validation of the instrument. Chapter 6 discussed the validation of the questionnaires and 
presented the findings of Phase 2. 
 
7.3 LIMITATIONS OF THE STUDY 
 
The limitations of the study were: 
 
The study population consisted of patients who received treatment for cancer at one public 
health care facility in one province in South Africa; however the expectation of the researcher is 
that the findings will be the same for cancer patients treated in other public health facilities in 
South Africa. 
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The sample size for Phase 2 of the study was relatively small, (n=47, n=44 and n=195), but 
compared favorably with the samples in other studies which developed and validated QoL 
instruments for cancer patients (Tripathy et al., 2015; Adnane et al., 2016).  
 
The structuring of the questions in the instrument is regarded as a limitation, as the questions 
could be confusing, especially for a person with a low literacy level.  It is proposed that the 
questions all be asked the same way, for example: Life is hard because I cannot sleep yes/no 
and Life is hard because I have severe pain yes/no.   
 
7.4 RECOMMENDATIONS  
 
7.4.1 Recommendations for further research 
 
The researcher recommends that the questions be revised to ensure that all the questions are 
structured the same way. The questions could be grouped according to domains of QoL found 
in Phase 1 of the study. It is further suggested that factors which have a positive influence on 
QoL not be included in a questionnaire which determines factors which have a negative 
influence on QoL, as it could be confusing to patients with a low educational level. If feasible, 
the number of questions should be further reduced to lessen the burden placed on cancer 
patients when completing the questionnaire. In addition, it is recommended that further 
research be done into the psychometric properties of the instrument and investigation be 
continued to refine the instrument.  
 
It is proposed that the instrument be tested further for internal consistency, convergent and 
discriminative validity. Internal consistency is a reliability issue and will determine the stability 
of the questions in the new instrument. Convergent and discriminant validity will be helpful to 
show how well the new instrument correlate with similar QoL instruments for cancer patients.   
 
Once validated for a population, it is proposed that the instrument be validated for other 
populations, for instance in other provinces in South Africa, and for other developing sub-
Saharan countries.  
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In future the researcher proposes that the instrument be tested in the clinical field in public 
health facilities, as well as in private hospitals and clinics where patients are treated who have 
medical insurance. The researcher would like to determine what the difference in QoL is of 
patients treated in public- and private health facilities and if the support needs of cancer 
patients treated in private facilities are the same as patients’ who are treated in public health 
facilities. 
 
Once the instrument is validated for African countries, the researcher suggests that it be tested 
in first world countries for applicability. 
 
7.4.2 Recommendations for nursing practice 
 
The researcher recommends that the instrument be used by oncology nurses to assess QoL of 
cancer patients during first- and subsequent visits to health care facilities, in order to identify 
problems which have a negative influence on QoL timeously. By identifying problems early and 
throughout the illness trajectory, nurses can develop and implement care plans tailored for the 
individual needs of patients. In addition, early identification would also allow patients to be 
referred to other members of the multi-disciplinary team such as psychologists and social 
workers for additional support. When problems are managed effectively, the QoL of cancer 
patients can be improved and maintained while having to cope with cancer and the treatment 
thereof.  
 
The researcher further recommends that the findings of the study be incorporated in the 
curriculum of Oncology Nursing Education to enhance evidence-based practice with regards to 
QoL of cancer patients. 
 
7.5 CONCLUSION 
 
This study supports the opinion that QoL is a complex, highly individual phenomenon. As seen 
in the study, QoL was influenced by various factors such as social- physical-, spiritual-, financial-, 
existential- and emotional factors. Using a patient-directed approach allowed the researcher to 
develop and pilot test a new QoL assessment instrument which includes all the relevant 
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domains of QoL for South African cancer patients. After validating the three questionnaires, the 
researchers found that Questionnaire 1: What makes life hard for you? (Addendum G) fitted 
the Rasch model best. In future the instrument will be referred to as the South African Quality 
of Life Instrument for Cancer Patients (SAQOLI-Ca).    
 
7.6 FINAL NOTE 
 
Through this study I, the researcher, learnt that the development of an instrument is a process 
which requires hard work and dedication and a learning curve with regards to the validation 
process. I sincerely hope that the QoL instrument which was developed will in future contribute 
to better QoL of cancer patients in South Africa. 
  
   
 
85 
 
REFERENCES 
ABRATT, R. & VOROBIOF, D. 2003. Cancer in Africa. The Lancet Oncology, 4, 394-396. 
ADNANE, C., OUBAHMANE, T., ADOULY, T., ELHANI, L., ROUADI, S., ABADA, R., ROUBAL, M. & 
MAHTAR, M. 2016. Cross-cultural and Moroccan validation of the University of 
Washington Quality of Life Questionnaire for patients with head and neck cancer. 
Annals of Otology, Rhinology & Laryngology, 125. 
ALBERS, G., ECHTELD, M., DE VET, C., ONWUTEAKA-PHILIPSEN, B., VAN DER LINDEN, M. & 
DELIENS, L. 2010. Evaluation of quality-of-life measures for use in palliative care: a 
systematic review. Palliative Medicine, 24, 17-37. 
ANDRICH, D. 2004. Controversy and the Rasch model: a characteristic of incompatable 
paradigms. Med Care, 2004 Jan. 
ANDRICH, D. & HAGQUIST, C. 2012. Real and artificial differential item functioning. Journal of 
educational and behavioral statistics, 37, 387-416. 
BARROSO, J. 2010. Introduction to Qualitative Research. In: LOBIONDO-WOOD, G. & HABER, J. 
(eds.) Nursing Research. Methods and Critical Appraisal for Evidence-Based Practice. St 
Louis: Mosby. 
BECKER, R. 2007. Psychosocial dimensions. In: S KINGHORN, S. G. (ed.) Palliative nursing. 
Improving end-of-life care. London: Elsevier. 
BEGLEY, C. 2008. Approaches to research. In: R WATSON, H. M., S COWMAN, J KEADY (ed.) 
Nursing research: designs and methods. Edinburgh: Elsevier. 
BELE, S., BODHARE, T., MUDGALKAR, N., SARAF, A. & VALSANGKAR, S. 2012. Health-related 
Quality of Life and Existential Concerns Among Patients with End-stage Renal Disease. 
Indian Journal of Palliative Care, 18, 103-108. 
BENNETT, M. & CLOSS, S. 2008. Clinical assessment and measurement. In: S PAYNE, J. S., C 
INGLETON (ed.) Palliative nursing: principles and evidence for practice. 2 ed. London: 
McGraw-Hill. 
BRINK, H. 2006. Fundamentals of research methodology for health care professionals, Cape 
Town, Juta. 
BUCKLEY, J. 2008. Palliative care: an integrated approach, West Sussex, Wiley-Blackwell. 
BURNS, N. & GROVE, S. 2009. The practice of nursing research: conduct, critique and utilization, 
St Louis, Elsevier. 
CANCER RESEARCH UK. 2012. Worldwide Cancer Statistics [Online]. Available: 
http://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-
cancer#heading-Zero [Accessed 2 July 2015]. 
CANSA. 2014a. South African cancer statistics [Online]. Cancer association of South Africa. 
Available: http://cansa.org.za [Accessed 7 March 2015. 
CANSA. 2014b. Making strides against cancer in South Africa [Online]. Cancer Association of 
South Africa. Available: 
http://www.nypcancerprevention.com/features/south_africa.html [Accessed 4 July 
2015]. 
CHIPPENDALE, S. 2001. Ethical issues in palliative care. In: S KINGHORN, R. G. (ed.) Palliative 
nursing: bringing comfort and hope. London: Bailliere Tindall. 
COHEN, S. 2006. Quality of life assessment in palliative care. In: BRUERA, E., HIGGINSON, I., 
RIPAMONTO, C. & VON GUTEN, C. (eds.) Textbook of palliative medicine. London: 
Hodder Arnold. 
CONSTANTINI, A., BAYLE, W., LENZI, R., CONSTANTINI, M., ZIPARO, V., MARCHETTI, P. & GRASSI, 
L. 2009. Overcoming cultural barriers to giving bad news: Feasibility of training to 
promote truth-telling to cancer patients. Journal of Cancer Education, 24, 180-185. 
   
 
86 
 
CORNER, J. 2008. Research and cancer care. In: J CORNER, C. B. (ed.) Cancer nursing. Care in 
context. 2 ed. Oxford: Blackwell. 
CRESSWELL, J. 2014. Research design: qualitative, quantitative, and mixed methods approaches, 
Thousend Oaks, Sage. 
CROWLEY, M. 2005. Supportive care: Dying and Death. In: ITANO, J. & TAOKA, K. (eds.) Core 
Curriculum for Oncology Nursing. 4th ed. St Louis: Elsevier. 
DENNY, L. 2015. Screening for cervical cancer in resource-limited settings [Online]. Wolters 
Kluwer. Available: http:www.uptodate.com/contents/screening-for-cervical-cancer-in-
resource-limited-settings [Accessed 10 September 2015]. 
DIEHR, P., LAFFERTY, W., PATRICK, D., DOWNEY, L., DEVLIN, S. & STANDISH, L. 2007. Quality of 
life at the end of life. 5. Available: http://www.hqlo.com/content/5/1/51 [Accessed 01 
November 2010]. 
DING, Y., HU, Y. & HALLBERG, I. 2012. Psychometric properties of the Chinese version of the 
Functional Assessment of Cancer Therapy-Cervix (FACT-Cx measuring health-related 
quality of life. Health and Quality of Life Outcomes, 2012, 124. 
DONAHOE, C., MCGILLYCUDDY, E. & REYNOLDS, J. 2011. Long-term health-related quality of life 
for disease-free esophageal cancer patients. World J Surg, 35, 1853-1860. 
DUNN, J., NG, S., BREITBART, W., AITKEN, J., YOUL, P., BAADE, P. & CHAMBERS, S. 2013. Health-
related quality of life and life satisfaction in colorectal cancer survivors: trajectories of 
adjustment. Health and Quality of Life Outcomes, 2013, 46. 
EGAN, R., MACLEOD, R., JAYE, C., MCGEE, R., BAXTER, J. & HERBISON, P. 2011. What is 
spirituality? Evidence of a New Zealand Hospice Study. Mortality: Promoting the 
interdisciplinery study of death and dying, 16, 307-324. 
FERRANS, C. 2011. Quality of life as an outcome of cancer care. In: YARBRO, C., WUJCIK, D. & 
GOBEL, B. (eds.) Cancer Nursing. Principles and Practice. Massachusetts: Jones and 
Bartlett. 
FERRANS, C. & HACKER, E. 2011. Quality of life as an outcome of cancer care. In: YARBRO, C., 
WUJCIK, D. & GOBEL, B. (eds.) Cancer Nursing. Principles and Practice Massachusetts: 
Jones and Bartlett Publishers. 
FITZSIMMONS, D. & MIDDLETON, J. 2006. The experience of cancer treatment. In: N KEARNEY, 
A. R. (ed.) Nursing patients with cancer. Principles and practice. Edinburgh: Elsevier. 
FORBES, L., WARNURTON, F., RICHARDS, M. & RAMIREZ, A. 2014. Risk factors for delay in 
symptomatic presentation: a survey of cancer patients. British Journal of Cancer, 111, 
581-588. 
GANY, F., LENG, J., RAMIREZ, J., PHILLIPS, S., ARAGONES, A., ROBERTS, N., MUJAWAR, M. & 
COSTAS-MUNIZ, R. 2015. Health-Related Quality of Life  of Food-Insecure Ethnic 
Minority Patients With Cancer. Journal of Oncology Practice, 11. 
GILLESPIE, T. 2011. Surgical therapy. In: YARBRO, M., WUJCIK, D. & GOBEL, B. (eds.) Cancer 
nursing. Principles and practice. Massachusetts: Jones and Bartlett  
GOSSELIN, T. 2011. Principles of Radiation Therapy In: YARBRO, C., WUJCIK, D. & GOBEL, B. 
(eds.) Cancer Nursing. Principles and practice. Massachusetts: Jones and Bartlett. 
GRIMM, P. 2005. Coping: Psychosocial issues. In: ITANO, J. & TAOKA, K. (eds.) Core Curriculum 
for Oncology Nursing. 4th ed. St Louis: Elsevier. 
GUTTERSRUD, O., DALANE, J. & PETTERSEN, S. 2013. Improving measurement in nutrition 
literacy research using Rasch modelling: examining construct validity of stage-specific 
'critical nutrition literacy' scales. Public Health Nutrition. 
   
 
87 
 
HAGERTY, R., BUTOW, P., ELLIS, P., DIMITRY, S. & TATTERSALL, M. 2005. Communicating 
prognosis in cancer care: a systematic review of the literature. Annals of Oncology, 16, 
1005-1053. 
HAGQUIST, C., BRUCE, M. & GUSTAVSSON, J. 2008. Using the Rasch model in nursing research: 
An introduction and illustrative example. International Journal of Nursing Studies 46, 
380-393. 
HAIGH, C. 2008. Research governance and research ethics. In: R WATSON, H. M., S COWMAN, J 
KEADY (ed.) Nursing research: designs and methods. Edinburgh: Elsevier. 
HEALTH24. 2014. Cancer in South Africa-what are the stats? [Online]. Available: 
http://www.health24.com/Medical/Prostate/Prostate-cancer-in-SA/Cancer-in-South-
Africa-what-are-the-stats-20120721. 
HODGSON, D. & TANNOCK, I. 2005. Guide to studies of diagnostic tests, prognostic factors and 
treatment. In: TANNOCK, I., HILL, R., BRISTOW, R. & HARRINGTON, L. (eds.) The basic 
science of oncology. Toronto: McGraw-Hill. 
HOWARD, P. & CHADY, B. 2012. Placement lerning in Cancer & Palliative Care nursing, Salford, 
Elsevier. 
INCTR. 2015. Cancer in Developing Countries. [Online]. International Network for Cancer 
Treatment and Research 
Available: http://www.inctr.org/about-inctr/cancer-in-developing-countries/ [Accessed 4 July 
2015]. 
JANSEN VAN RENSBURG, J. 2011. Quality of life from the perspective of the palliative patient. M 
Tech Dissertation, Tshwane University of Technology. 
JANSEN VAN RENSBURG, J., MAREE, J. & VAN BELKUM, C. 2012. Quality of life from the 
perspective of the palliative patient in a resource-poor community of South Africa. 
Palliative and Supportive Care, 11, 1-8. 
KHADKA, J., GOTHWAL, V., MCALINDEN, C., LAMOUREUX, E. & K PESUDOVS, K. 2012. The 
importance of rating scales in measuring patient-reported outcomes. Health and Quality 
of Life Outcomes, 10. 
KHOSHNEVISAN, A., YEKANINEJAD, M., ARDAKANI, S., PAKPOUR, A., MARDANI, A. & 
AARONSON, N. 2012. Translation and validation of the EORTC brain cancer module 
(EORTC QLQ-BN20) for use in Iran. Health and Quality of Life Outcomes, 10. 
KRISTJANSON, L. 2001. Establishing goals: communication traps and treatment lane changes. In: 
FERRELL, B. & COYLE, N. (eds.) Textbook of palliative nursing. Oxford: University Press. 
LOBIONDO-WOOD, G. & HABER, J. 2010. Nursing research: methods and critical appraisal for 
evidence-based practice, St Louis, Mosby. 
LYONS, K., BAKITAS, M., HEGEL, M., HANSCOM, B., HULL, J. & AHLES, T. 2009. Reliability and 
validity of the Functional Assessment of Chronic Illness Therapy- Palliative Care (FACIT-
Pal) Scale. Journal of Pain and Symptom Management, 37, 23-32. 
MAHER, D., FORD, N. & UNWIN, N. 2012. Priorities for developing countries in the global 
response to non-communicable diseases. Globalization and Health, 8. 
MALLINSON, T. 2007. Why measurement matters for measuring patient vision outcomes. 
Optometry & Vision Science, 84, 675-682. 
MANDZUK, L. & MCMILLAN, D. 2005. A concept analysis of quality of life. Journal of orthopedic 
nursing, 9, 12-18. 
MAREE, J. 2011. Registered nurse awareness of and practice related to cancer pain. In: CHOW, 
E. & MERRICK, J. (eds.) Advanced cancer. Pain and quality of life. New York: Nova 
Science Publishers. 
   
 
88 
 
MAREE, J. & JANSEN VAN RENSBURG, J. 2015. Suitability of quality-of-life outcome measures in 
palliative care in the South African setting. Palliative and Supportive Care, 1-11. 
MAREE, J., LANGLEY, G. & NQUBEZELO, L. 2014. "Not a nice experience, not at all": 
Underprivileged women's experiences of being confronted with cervical cancer. 
Palliative and Supportive Care, 1-9. 
MCCARTHY, G. & O'SULLIVAN, D. 2008. Evaluating the literature. In: WATSON, R., MCKENNA, 
H., COWMAN, S. & KEADY, J. (eds.) Nursing research. Design and methods. Edinburgh: 
Elsevier. 
MITCHELL, A. 2001. Quality of life in palliative care: patient as expert. In: S KINGHORN, R. G. 
(ed.) Palliative nursing:bringing comfort and hope. London: Balliere Tindall. 
MITERA, G., ZEIADIN, N., SAHGAL, A., FINKELSTEIN, J., CHOW, E. & LOBLAW, A. 2010. Can we 
measure quality of life for patients with metastatic spinal cord compression. In: CHOW, 
E. & MERRICK, J. (eds.) Advanced cancer. Pain and quality of life. New York: Nova 
Science Publishers. 
MOJAKI, M., BASU, D., LETSKOKGOHKA, M. & GOVENDER, M. 2011. Referral steps in district 
health system are side-stepped. SAMJ, 101, 109-109. 
MOORE, C. 2007. Advance care planning and end-of-life-decision making. In: KUEBLER, K., 
HEIDRICH, D. & ESPER, P. (eds.) Palliative & End-of-Life Care. St Louis: Elsevier. 
MORHASON-BELLO, I., ODEHINA, F., REBBECK, T., HARFORD, J., DANGOU, J., DENNY, L. & 
ADEWOLE, I. 2013. Challenges and opportunities in cancer control in Africa: a 
perspective from the African Organisation for Research and Training in Cancer. The 
Lancet Oncology, 14, 142-151. 
NHLS 2008. National cancer registry. 
NHS. 2015. NHS cancer screening [Online]. Online: NHS. Available: 
http://www.nhs.uk/Livewell/preventing-cancer/Pages/cancer-screening.aspx [Accessed 
5 September 2015]. 
NISHIMOTO, P. 2005. Sexuality. In: ITANO, J. & TAOKA, K. (eds.) Core Curriculum fo Oncology 
Nursing. St Louis: Elsevier. 
PALLANT, J. & TENNANT, A. 2007. An introduction to the Rasch measurement model: An 
example using the Hospital Anxiety and Depression Scale (HADS). British Journal of 
Clinical Psychology, 46, 1-18. 
PATTON, M. 2002. Qualitative research & evaluation methods, California, Sage. 
POLIT, D. & BECK, C. 2008. Nursing research: generating and assessing evidence for nursing 
practice., Philadelphia. 
PORTER, P. 2009. Global trend in breast cancer incidence and mortality. Salud publica Mex, 51. 
QUINNE, C. & CLARE, L. 2008. Interpretive phenomenological analysis. In: E WATSON, H. M., S 
COWMAN, J KEADY (ed.) Nursing research: design and methods. Edinburgh: Elsevier. 
ROMERO, M., VIVAS-CONSUELO, D. & ALVIS-GUZMAN, N. 2013. Is Health Related Quality of Life 
(HRQOL) a valid indicator for health systems evaluation? SpringerPlus 2. 
SCHUTTE, L., WISSING, M., ELLIS, S., JOSE, P. & VELLA-BRODRICK, D. 2016. Rasch analysis of the 
Meaning of Life Questionnaire among adults from South Africa, Australia, and New 
Zealand. Health and Quality of Life Outcomes, 14. 
SEARLE, C. 2001. Spirituality: the prefessionals' and the patients' perspectives. In: KINGHORN, S. 
& GAMLIN, R. (eds.) palliative Nursing. Bringing Comfort and Hope. Edinburgh: Bailliere 
Tindall. 
SHAKERI, J., KMANGAR, M., EBRAHIMI, E., AZNAB, M., SHAKERI, H. & ARMAN, F. 2015. 
Association of Coping Styles with Quality of Life in Cancer Patients. Indian Journal of 
Palliative Care, 21. 
   
 
89 
 
SHENTON, A. 2004. Strategies for ensuring trustworthiness in qualitative research projects. 
Education for Information 22, 63-75. 
SITAS, F., PARKER, M., CHIRENJE, Z., STEIN, L., MQOQI, N. & WABINGA, H. 2006. Cancers. In: 
JAMISON, D., FEACHEM, R., MAKGOBA, M., BOS, E., BAINGANA, F., HOFMAN, K. & 
ROGO, K. (eds.) Disease and Mortality in Sub-Saharan Africa. 2nd ed. Washington: 
World Bank. 
SOUTHAFRICA.INFO. 2015. Health care in South Africa [Online]. South Africa: SouthAfrica.info. 
Available: http://www.southafrica.info/about/health/health.htm#.VQKrGtKUdZ4 
[Accessed 13 March 2015]. 
STREUBERT, H. 2010. Approaising qualitative research. In: LOBIONDO-WOOD, G. & HABER, J. 
(eds.) Nursing Research. Methods and Clinical Appraisal for Evidence-Based Practice. St 
Louis: Mosby. 
TENNANT, A. & CONAGHAN, P. 2007. The Rasch Measurement Model in Rheumatology: What is 
it and why use it? When should it be applied, and what should one look for in a Rasch 
paper? Arthritis & Rheumatism, 57, 1358-1362. 
THEOFILOU, P. 2012. The Missoula-Vitas Quality of Life Index. Journal of Palliative Care & 
Medicine, 1, 1-2. 
THOMPSON, C. & BAKER, R. 2008. Q Methodology in Nursing Research. In: WATSON, R., 
MCKENNA, H., COWMAN, S. & KEADY, J. (eds.) Nursing Research. Design and Methods. 
Edinburgh: Elsevier. 
TONG, A., SAINSBURY, P. & CRAIG, J. 2007. Consolidated criteria for reporting qualitative 
research (COREQ): a 32 item checklist for interviews and focus groups. International 
Journal for Quality in Health Care, 19, 349-357. 
TORTORICE, P. 2011. Cytotoxic Chemotherapy: Principles of Therapy. In: YARBRO, C., WUJCIK, 
D. & GOBEL, B. (eds.) Cancer Nursing. Principles and Practice. Massachussets: Jones and 
Bartlett. 
TRIPATHY, S., HANSDA, U., SETH, N., RATH, S., RAO, P., MISHRA, T., SUBBA, S., DAS, R., NAYAK, 
S. & KAR, N. 2015. Validation of the EuroQol Five-dimensions-Three level Quality of Life 
Instrument in a Classical Indian Language (Odia) and Its Use to access Quality of Life and 
Health Status of Cancer Patients in Eastern India. Indian Journal of Palliative Care, 21. 
TSEWAT, J. 2006. Spirituality/Religion and quality of life in patients with HIV/AIDS. J Gen Intern 
Med, 21. 
UWIMANA, J. 2005. Met and unmet palliative care needs for people living with HIV/AIDS in 
selected areas in Rwanda. M Sc, University of the Western Cape. 
WEIN, S. 2014. Spirituality-The psyche or the soul. Palliative and Supportive Care, 12, 91-94. 
WHO. 1997. WHOQOL Measuring quality of life [Online]. World Health Organization. 
WHO 2005. Global action against cancer. Geneva: WHO Press. 
WHO. 2012. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide 
in 2012 [Online]. International Agency for Research on Cancer. Available: 
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx [Accessed 7 January 2014]. 
WIKIPEDIA. 2015. Charlotte Maxeke Johannesburg Acedemic Hospital [Online]. Available: 
http://en.wikipedia.org/wiki/Charlotte_Maxeke_Johannesburg_Academic_Hospital 
[Accessed 13 March 2015]. 
ZENG, Y., CHING, S. & LOKE, A. 2010. Quality of life measurement in women with cervical 
cancer: implications for Chinese cervical cancer survivors. Health and quality of life 
outcomes, 8. 
   
 
90 
 
ZUCCA, A., LAMBERT, S., BOYES, A. & PALLANT, J. 2012. Rasch analysis of the Mini-Mental 
Adjustment to Cancer Scale (mini-mac) among heterogenous sample of long-term 
cancer survivors: a cross-sectional study. Health and Quality of Life Outcomes 10. 
 
  
   
 
91 
 
ADDENDUM A 
 
QUESTIONNAIRE FOR PATIENT DEMOGRAPHIC DATA 
 
 Office use 
 1.  How old are you?                        yrs       Q1= 
2.  What is your gender? Male  1 Q2= 
 Female 2  
3.  Which cultural group do you belong to?  1 Q3= 
4.  Which grade did you complete at school?   Q4= 
5.  Are you  
 Married customary  1 Q5= 
 Married culturally  2  
 Single  3  
 Divorced  4  
 Widowed  5  
 Separated  6  
 Living with a partner 7  
6.  What kind of cancer do you suffer from?  1 Q6= 
7.  How long have you been ill?                       months/years Q7= 
8.  What treatment do you receive?                 Chemotherapy 1 Q8= 
 Radiation therapy 2  
 Chemotherapy and 
radiation 
3  
9. Which medication are you using?  
 
 
 
Q9= 
10. Who takes care of you?  Q10= 
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ADDENDUM B 
TOPIC GUIDE 
 
The following themes will be explored: 
 
What makes life good  
 Generally 
 Physically 
 Psychosocially 
 Spiritually 
 
What makes life hard  
 Generally 
 Physically 
 Psychosocially 
 Spiritually 
 
How patient feels about current life 
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ADDENDUM C 
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ADDENDUM D 
 
Nursing Education 
CONFIDENTIALITY AGREEMENT: INTERPRETER 
 
I, ________________________________________, ID number    
______________________________________ hereby declare that I am willing to assist Mrs 
Kotie Jansen van Rensburg during interviews for her PhD study, by interpreting in case a 
participant in the study does not understand a question asked in Afrikaans or English. I 
understand that all information obtained during the interviews has to be kept confidential.  
 
 
Signature: ______________________________ Date: ____________________ 
 
Witness:   ______________________________ Date: ____________________ 
 
Witness:  _______________________________ Date: ____________________  
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ADDENDUM E 
 
Nursing Education 
INFORMATION LEAFLET AND INFORMED CONSENT 
 
TITLE: DEVELOPMENT AND VALIDATION OF A QUALITY OF LIFE ASSESSMENT INSTRUMENT 
FOR CANCER PATIENTS IN SOUTH AFRICA 
 
Dear Patient 
 
My name is Kotie Jansen van Rensburg. I am a student at the University of the Witwatersrand, 
Department of Nursing Education. I would like to invite you to take part in a study that I am 
conducting in this Oncology Unit where you are receiving your treatment for cancer. This 
information leaflet is to help you to decide if you would like to participate. Before you agree to 
take part in the study, you should fully understand what is involved. If you have any questions 
which are not fully explained in this leaflet, do not hesitate to phone me, Kotie Jansen van 
Rensburg at 082 822 7989 or my supervisor, Professor Lize Maree at 011 488 4196 during office 
hours. You should only agree to take part if you are completely satisfied with all the procedures 
involved. 
 
What is the study all about? 
 
I would like to find out how you feel about your life at present: what makes life good for you 
and what makes life hard for you. Talking to me about your life will help me to understand what 
is important for cancer patients to live a good life and then I will be able to help to improve the 
lives of cancer patients in South Africa. 
 
What will you need to do in the study? 
 
If you agree to take part in the study, I will first ask you to sign a consent form. This form is to 
show that you will allow me to talk to you and use the information that you give me. If you 
agree, I will use a voice recorder during the interview, so that I can listen to what you said when 
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I am at home and can type everything you said. If you do not agree, I will not record the 
interview and will make notes during the interview. I would ask you to tell me a little of yourself 
like how old you are, who takes care of you and what type of cancer you are suffering from. 
After that I will talk to you about your experience of life at present. This will take about one 
hour of your time. If you get very upset or tired during the interview, you may ask me to stop 
for a while or you may refuse to continue with the interview. 
 
Are there any conditions that may exclude you from the study? 
 
You have to be a patient at the Oncology unit, receiving chemotherapy or radiation therapy or 
both for cancer and be older than 18 years. 
 
What are the risks involved in this study? 
 
You might become sad when you tell me about your experience of having cancer and receiving 
treatment. Unfortunately this is the only way that I can find out how you feel about your life at 
present. If you are upset I will be able to refer you to a very experienced counselor who will 
help you discuss your distress or anxiety and give you some assurance about your illness and 
the treatment you are undergoing. As mentioned previously, you may decide at any time during 
the interview that you don’t want to be in the study, or that you need a break before 
continuing with the interview. You are perfectly within your rights and, if you do decide to 
withdraw, your decision will not have any effect on the normal treatment you would receive at 
the Oncology unit.   
 
What are the potential benefits that may come from the study? 
 
By participating in this study you will help me to understand how cancer patients in South 
Africa experience cancer and the treatment for cancer and what is important for them in their 
lives. This would help me find a way to serve patients better. There are, however, no benefits 
for you personally and you will not be paid to participate in the study. 
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What are your rights as a participant in this study? 
 
You can choose if you want to take part in the study. You can also, during the interview, say 
that you do not want to take part any more. You can even tell me that I cannot use the 
information after you have talked to me. Once I have taped what you have said, I will wipe out 
your name and nobody will know that this is what you said. I will not share your personal 
information and your name with anybody and will use a pseudonym when talking about the 
information that you shared with me. A pseudonym is another name that I will call you that 
nobody else knows about. 
 
How will confidentiality and anonymity be ensured for the study? 
 
What you say to me is strictly confidential and only I would be able have access to your 
information. I will not identify you in any way on my records – your information will be given a 
code number which cannot be traced back to your name. When I type what you said, I will 
remove your name and use the pseudonym which I told you about previously. Your real name 
will not be used when I write the report.   
 
Has the study received ethical approval? 
 
Before asking you to take part in the study, the Human Research Ethics Committee of the 
University of the Witwatersrand and the Ethics Committee of the Gauteng Health Department 
will approve the study. Should you have any questions regarding the ethical aspects of the 
study, you can contact the chairperson of the Ethics Committee Prof Peter Cleaton-Jones on 
011-7172100. 
 
Thank you for taking the time to consider joining the study. If you have any further questions, 
please contact me. 
 
Yours sincerely, 
 
Kotie Jansen van Rensburg 
Cell: 082 822 7989 
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Informed consent 
 
I confirm that I have been informed by the investigator about the nature, conduct, benefits and 
risks of the study. I have also received, read and understood the above written information 
(Patient Information Leaflet and Informed Consent) regarding the study.   
 
I am aware that the results of the study, including my personal details will be anonymously 
processed into a research report.  I understand that I may withdraw my consent and 
participation in the study.  I had sufficient opportunity to ask questions and (of my own free 
will) declare myself prepared to participate in the study. 
 
Participant’s name       (Please print) 
 
Participant’ signature       Date    
 
Investigator’s name       (Please print) 
 
Investigator’s signature      Date    
 
I, ……………………………………………. (field worker) herewith confirm that the above participant has 
been informed fully about the nature, conduct and risks of the above study. 
 
Witness’s name*        (Please print) 
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ADDENDUM F 
 
Nursing Education 
INFORMATION LEAFLET AND INFORMED CONSENT 
 
TITLE: DEVELOPMENT AND VALIDATION OF A QUALITY OF LIFE ASSESSMENT INSTRUMENT 
FOR CANCER PATIENTS IN SOUTH AFRICA 
 
Dear Patient 
 
My name is Kotie Jansen van Rensburg. I am a student at the University of the 
Witwatersrand, Department of Nursing Education. I would like to invite you to take part in 
a study that I am conducting in this Oncology Unit where you are receiving your treatment 
for cancer. This information leaflet is to help you to decide if you would like to participate. 
Before you agree to take part in the study, you should fully understand what is involved. If 
you have any questions which are not fully explained in this leaflet, do not hesitate to 
phone me, Kotie Jansen van Rensburg at 082 822 7989 or my supervisor, Professor Lize 
Maree at 011 488 4196 during office hours. You should only agree to take part if you are 
completely satisfied with all the procedures involved. 
 
What is the study all about? 
 
I would like to find out how you feel about your life at present: what makes life good for you 
and what makes life hard for you. Talking to me about your life will help me to understand what 
is important for cancer patients to live a good life and then I will be able to help to improve the 
lives of cancer patients in South Africa. 
 
What will you need to do in the study? 
 
If you agree to take part in the study, I will first ask you to sign this consent form. This form is to 
show that you will complete a short questionnaire and allow me to use the information that 
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you give me. I would ask you to tell me a little of yourself like how old you are, which cultural 
group you belong to and what type of cancer you are suffering from. You will be asked to fill in 
a questionnaire, which will take about 20 minutes of you time. If you get very upset or tired 
while completing the questionnaire, you may ask to stop for a while or you may refuse to 
continue with the questionnaire. 
 
Are there any conditions that may exclude you from the study? 
 
You have to be a patient at the Oncology unit, receiving chemotherapy or radiation therapy or 
both for cancer and be older than 18 years. 
 
What are the risks involved in this study? 
 
You might become sad when filling in the questionnaire about your experience of having cancer 
and receiving treatment. Unfortunately this is the only way that I can find out how you feel 
about your life at present. If you become upset I will be able to refer you to a very experienced 
counselor who will help you to discuss your distress or anxiety and give you some assurance 
about your illness and the treatment you are undergoing. As mentioned previously, you may 
decide at any time during the completion of the questionnaire that you don’t want to be in the 
study, or that you need a break before continuing. You are perfectly within your rights and, if 
you do decide to withdraw, your decision will not have any effect on the normal treatment you 
would receive at the Oncology unit.   
 
What are the potential benefits that may come from the study? 
By participating in this study you will help me to understand how cancer patients in South 
Africa experience cancer and the treatment for cancer and what is important for them in their 
lives. This would help me find a way to serve patients better. There are, however, no benefits 
for you personally and you will not be paid to participate in the study. 
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What are your rights as a participant in this study? 
You can choose if you want to take part in the study. You can also, during the completion of the 
questionnaire, say that you do not want to take part any more. You can even tell me that I 
cannot use the information after you have completed the questionnaire.  
 
How will confidentiality and anonymity be ensured for the study? 
 
What you say to me is strictly confidential and only I would be able have access to your 
information. I will not identify you in any way on my records – your questionnaire will not 
contain your name, but will be given a number which cannot be traced back to your name.   
 
Has the study received ethical approval? 
 
The Human Research Ethics Committee of the University of the Witwatersrand and the Ethics 
Committee of the Gauteng Health Department have approved the study. Should you have any 
questions regarding the ethical aspects of the study, you can contact the chairperson of the 
Ethics Committee Prof Peter Cleaton-Jones on 011-7172100. 
 
Thank you for taking the time to consider joining the study. If you have any further questions, 
please contact me. 
 
Yours sincerely, 
 
Kotie Jansen van Rensburg 
Department of Nursing Education   Tel:  011 488 4268 or Cell: 082 822 7989  
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Informed consent 
 
I confirm that I have been informed by the investigator about the nature, conduct, benefits and 
risks of the study. I have also received, read and understood the above written information 
(Patient Information Leaflet and Informed Consent) regarding the study.   
 
I am aware that the results of the study, including my personal details will be anonymously 
processed into a research report.  I understand that I may withdraw my consent and 
participation in the study.  I had sufficient opportunity to ask questions and (of my own free 
will) declare myself prepared to participate in the study. 
 
Participant’s name       (Please print) 
 
Participant’s signature      Date    
 
Investigator’s name       (Please print) 
 
Investigator’s signature      Date    
 
I, ……………………………………………. (field  worker) herewith confirm that the above participant has 
been informed fully about the nature, conduct and risks of the above study. 
 
Witness’s name*        (Please print) 
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ADDENDUM G 
 
Questionnaire 1: What makes life hard for you? 
General information: 
Question Answer  Office use 
1.  How old are you?         years  Q1= 
2.  What is your gender Male 1 Q2= 
 Female 2  
3.  Which cultural group do you belong to?  1 Q3= 
4.  What is your highest qualification?  1 Q4= 
5. What kind of cancer do you have?   Q5= 
 
Which of the following make life hard for you? 
No Question Yes No Unsure 
1. Not being able to do what you did before the cancer    
2. Being too tired to carry out your normal activities of daily living    
3. Not being able to work    
4. Not being able to enjoy life    
5. Not being able to keep busy    
6. Not being able to have a sexual relationship    
7. Being told to eat different foods    
8. Experiencing physical problems like:    
  Not being able to eat    
  Not being able to sleep    
  Losing your hair    
  Having diarrhea    
  Having constipation    
  Suffering from nausea and vomiting    
  Experiencing changes in smell sensation    
  Experiencing changes in taste sensation    
  Suffering from bleeding    
  Having pain    
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No Question Yes No Unsure 
  Suffering from piles    
  Feeling dizzy    
  Experiencing skin changes    
  Experiencing swelling of your legs and feet    
  Getting cramps    
  Seeing stars before your eyes    
  Feeling tired most of the time    
  Suffering from hot flushes    
9. Not being able to do what others do    
10. Having to get up very early to go to the hospital     
11. Having to travel far to the hospital    
12. Not feeling good about your  body     
13. Losing weight    
14. Not being able to be as active as before    
15. Not being able to take part in religious activities  like prayer, singing, 
attending church and worshipping 
   
16. Being separated from your family    
17. Experiencing changes in your relationships with others    
18. Not being able to care for yourself    
19. Not getting support from your friends and family    
20. Experiencing difficulties with traveling to the hospital    
21. Not being able to manage your work     
22. Having to keep on working while sick    
23. Not being able to visit your friends    
24. Struggling to come to hospital due to lack of money    
25. Not having money for the right foods     
26. Losing your job because of the illness    
27. Being financially dependent on others    
28. Not having enough money for food for your family    
29. Having to cope with the diagnosis of cancer    
30. Having to face negative people    
31. Being upset about losing weight    
32. Feeling embarrassed about your symptoms    
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No Question Yes No Unsure 
33. Feeling depressed    
34. Feeling angry    
35. Feeling unsure about the future    
36. Feeling hopeless    
37. Being scared of death    
38. Not having hope for the future    
39. Worrying about what will happen to your children and family    
40. Feeling like ending your life    
41. Not being able to enjoy life    
42. Not being informed about cancer and the treatment    
43. Being scared of the unknown    
44. Feeling worried about your work    
45. Feeling like less of a woman / man    
46. Being scared of people’s reactions when they hear that you have 
cancer 
   
47. Missing your children and family    
48. Feeling you have too much to cope with    
49. Not being able to plan for the future    
50. Not being able to fulfill your role as a parent / partner    
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ADDENDUM H 
Questionnaire 2: What makes life good for you? 
General information: 
Question Answer  Office use 
1.  How old are you?         years  Q1= 
2.  What is your gender Male 1 Q2= 
 Female 2  
3.  Which cultural group do you belong to?  1 Q3= 
4.  What is your highest qualification?  1 Q4= 
5. What kind of cancer do you have?   Q5= 
 
Please tell me which of the following make life good for you? 
No Question Yes No Unsure 
1. Being able to eat    
2. Not losing weight    
3. Not having pain    
4. Being able to keep busy    
5. Getting relief of symptoms through medication    
6. Learning through the experience of cancer    
7. Being able to make peace with having cancer    
8. Being able to do what you did before the cancer (cooking, cleaning, 
working) 
   
9. Being able to take care of yourself and your family    
10. Finding ways of earning money at home    
11. Being able to enjoy activities like reading, watching TV, singing and 
dancing 
   
12. Not having difficulties to come to the hospital    
13. Being able to maintain your relationships with your friends    
14. Being able to talk to other patients about cancer    
15. Getting support from members of your church    
16. Having a good relationship with your partner and family    
17. Being able to spend time with your family    
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No Question Yes No Unsure 
18. Being informed about your illness and treatment    
19. Receiving treatment from caring staff    
20. Being able to be positive despite of your illness    
21. Not being afraid of the future    
22. Being able to enjoy life    
23. Receiving support from your partner, family and friends    
24. Being able to talk to somebody about your illness    
25. Feeling in control of your life    
26. Being able to take part in spiritual activities like prayer, song, 
worshipping, reading the Bible and going to church 
   
27. Feeling closer to God because of the cancer    
28. Growing spiritually    
29. Believing God is in control of the cancer and your life    
30. Feeling blessed despite having cancer    
31. Believing in eternal life    
32. Experiencing the love and grace of God during your illness and 
treatment 
   
33. Accepting suffering and death as part of life    
34. Not being afraid of death    
35. Experiencing love and friendliness when you are with members of 
your church 
   
36. Being able to support other patients with cancer    
37. Having hope to live a normal life in future    
38. Being able to use your experience of cancer to encourage others to 
live close to God 
   
39. Being able to believe that your illness is part of God’s plan for your 
life 
   
40. Being able to be strong for your family    
41. Having hope for a better future without pain and suffering    
42. Being able to see death as part of life    
43. Being able to get your matters in order    
44. Being able to pay for your own and your family’s expenses    
45. Having a job    
   
 
108 
 
No Question Yes No Unsure 
46. Having financial support from your partner / family    
47. Having an income    
48. Having a job to return to after your treatment    
49. Being able to live one day at a time and be grateful    
50. Being able to fulfill your roles as a mother / father / spouse / friend     
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ADDENDUM I 
Questionnaire 3: What makes your life good or hard? 
General information: 
Question Answer  Office use 
1.  How old are you?         years  Q1= 
2.  What is your gender Male 1 Q2= 
 Female 2  
3.  Which cultural group do you belong to?  1 Q3= 
4.  What is your highest qualification?  1 Q4= 
5. What kind of cancer do you have?   Q5= 
 
Please answer all the questions 
No Question Yes No 
1. Life is hard because I am too tired to do what I did before the cancer   
2. Life is hard because I am not able to work   
3. Cancer is making life difficult for me at the moment   
4. Life is hard because I am not able to keep busy   
5. Life is hard because I have to eat different foods   
6. Life is hard because I cannot eat   
7. Life is hard because I cannot sleep   
8. Life is hard because I am losing my hair   
9. Life is hard because I have diarrhea   
10. Life is hard because I have a problem with constipation   
11. Life is hard because I am suffering from nausea and vomiting   
12. Life is hard because I cannot taste the food or the food tastes different   
13. Life is hard because I am bleeding a lot   
14. Life is hard because I have severe pain   
15. Life is hard because I often feel dizzy   
16. Life is hard because I am experiencing changes in my skin   
17. Life is hard because I suffer from cramps   
18. Life is hard because I suffer from hot flushes   
19. Life is hard because I cannot do what others do   
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No Question Yes No 
20. Life is hard because I have to get up early and travel far to the hospital 
for treatment 
  
21. Life is hard for me because the cancer changed my body   
22. Life is hard for me because I am losing weight   
23. Life is good because my symptoms are controlled well by the 
medication 
  
24. Life is hard because I cannot have a sexual relationship due to the 
cancer 
  
25. Life is hard for me because I am separated from my family   
26. Life is hard for me because my relationships with my friends and 
family have changed 
  
27. Life is hard for me because I am not able to take care of myself and my 
family 
  
28. Life is hard because I cannot visit my friends   
29. Life is hard because I am worried about my work   
30. Life is hard for me because I cannot fulfill my role as a parent / partner   
31. Life is good because I can read, watch TV and sing   
32. Talking to other patients about cancer makes life good for me   
33. I have a good relationship with my partner and family   
34. The staff at the hospital are friendly and caring   
35. My partner, family and friends support me   
36. Being able to work makes life good for me   
37. Life is hard for me because I cannot go to church   
38. Taking part in activities like prayer, song, reading the Bible and going 
to church makes life good for me 
  
39. I feel closer to God because of the cancer   
40. The support which I get from members of the church makes life good 
for me 
  
41. I believe God is in control of the cancer and my life   
42. Using my experience of cancer to encourage others to live close to 
God makes life good for me 
  
43. Life is hard because I do not have money for transport to come to the 
hospital 
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No Question Yes No 
44. Life is hard because I have to keep on working while I am sick   
45. Life is hard because I have to depend on my friends and family for 
financial support 
  
46. I find it difficult to cope with having cancer   
47. I find it difficult to face negative people   
48. I feel embarrassed about my symptoms   
49. I feel depressed most of the time   
50. I feel angry most of the time   
51. I feel hopeless most of the time   
52. I am scared of dying   
53. I am worried about my family and children   
54. I feel scared because I do not know what is going to happen to me   
55. I feel like less of a man / woman because of the cancer   
56. I feel positive despite having cancer   
57. I am not afraid of the future   
58. I can still enjoy life despite having cancer   
59. I feel in control of my life   
60. I am able to be strong for my family   
61. Life is hard because I cannot plan for the future   
62. I feel I am learning through my experience of cancer   
63. I have made peace with having cancer   
64. I accept suffering and death as part of life   
65. Being able to support other patients with cancer makes life good for 
me 
  
66. I am able to get my matters in order   
67. I have hope for a better future without pain and suffering   
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ADDENDUM J 
 
Interview 1: 28 June 
 
K Good morning Poppy 
P How are you? 
K I’m fine and you? 
P I’m good, thanks 
K Thank you very much for agreeing to talk to me. What I would like to find out from you 
is: what makes life good for you? 
P Just living life. It’s the best thing ever: living life as it comes. 
K So, are there things that you do... or relationships maybe that make life good for you? 
P Yes... having someone that’s there for you...that cares for you and supports you...that 
makes it better. 
K So, who is supporting you? 
P My mom and my boyfriend 
K Is there anything about your body that makes life good for you. 
P Yes, it’s a stable body. When I’m sick it doesn’t drastically go down... I don’t like to use 
weight...being thin, thin thin...it’s just normal. 
K OK...so to keep your weight is important to you 
P Yes. 
K You don’t want to be thin 
P No, I don’t. (laughs). 
K Has the illness affected your body in any way? 
P Not really, it hasn’t actually, no. 
K You are looking well. You look beautiful. 
P Thank you 
K Has the illness had any influence on you spiritually? 
P Yes, it taught me to kneel down more and concentrate on God more than I used to. 
K Can you tell me more about that? 
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ADDENDUM K 
ETHICAL APPROVAL 
 
